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Abstract 
We investigate how other high-income countries have thought about and implemented 
changes to their funding systems for health and social care to better meet the challenges 
ahead. This paper is part of a broader project funded by the Health Foundation, which 
aims to identify a range of feasible options for the future funding of health and social care 
in the four countries of the UK, and assess the relative (un-)attractiveness of different 
funding approaches to the general public. The research reported here examines trends 
and innovations in health and social care funding in a selection of high-income countries. 
We focus on where the money to pay for care comes from, not on how it is then spent. 
Drawing on a review of the literature and interviews with 30 key informants in a range of 
high-income countries, we explore current thinking on the options for funding health care 
and social care. Our aim is to add to the evidence base and improve the quality of the 
debate, rather than make recommendations. Specifically, we: 
• provide examples of funding configurations for health and social care, as well as 
changes that have been implemented, or are being considered, in a range of high-
income countries 
• explore the drivers of recent or planned health and social care funding changes 
and reforms and the contexts within which decisions around funding were taken 
• highlight key points that can inform the range of conceivable options for funding 
health care and social care in the four countries of the UK. 
Overall we find that: 
• most reviewed countries fund health care primarily from public sources, such as 
taxation and mandatory health insurance, while social care often relies to a 
comparatively greater extent on individuals paying privately 
• health and social care funding reforms tend to be incremental rather than radical, 
are path-dependent, and are catalysed by changes in economic conditions rather 
than by rising demand for care  
• high-income countries have taken diverse approaches to tackling the need to 
increase health and social care funding and there is no single optimal, or 
commonly preferred, solution to achieving sustainable revenues.  
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Glossary 
ACA – Patient Protection and Affordable Care Act 2010 (USA) 
ACC – Accident Compensation Corporation (New Zealand) 
ADL – Activities of daily living 
AME – Aide Médicale d'État (France) 
APA – Allocation Personnalisée d’Autonomie (France) 
CASA – Contribution Additionnelle de Solidarité pour l'Autonomie (France) 
CMU – Couverture Maladie Universelle (France) 
CNAMTS – Caisse Nationale de l'Assurance Maladie des Travailleurs Salariés (France) 
DPA – Deferred payment arrangement (UK) 
GDP – Gross domestic product 
GST – Goods and services tax (New Zealand) 
IADL – Instrumental activities of daily living 
LTC – Long-term care 
LTCI – Long-term care insurance 
OECD – Organisation for Economic Co-operation and Development 
OOP – Out-of-pocket (expenditure) 
PHI – Private health insurance 
PPP – Purchasing power parity (adjusted exchange rate) 
SHI – (Mandatory) Statutory health insurance 
VHI – Voluntary health insurance 
WHO – World Health Organization 
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Summary 
The demand for health and social care is rising and this is for good reasons. We are living 
longer and, as a consequence, the number of older people is growing rapidly. Coupled with 
the rising burden of multiple chronic disease and increasing frailty at older ages, this means 
that the number of people needing support in their daily lives through health and social care 
is also rising. This comes alongside accelerated advances in medical technology and 
knowledge that provide significant potential for new methods of delivering and organising 
care. Demand for social care and health care is rising faster than the public funds that are 
being made available to spend on them in all four countries of the UK, leaving a large and 
growing funding gap. 
The UK is not the only country facing these challenges and there is  potential to learn from 
the experiences in other countries to identify possible ways to address these difficulties in 
the UK. In this paper, we seek to understand how other high-income countries have thought 
about and implemented changes to their funding systems for health and social care to better 
meet the challenges ahead. 
This paper is part of a broader project funded by the Health Foundation, which aims to 
identify a range of feasible options for the future funding of health and social care in the four 
countries of the UK, and assess the relative (un-)attractiveness of different funding 
approaches to the general public. Conducted by RAND Europe, in collaboration with the 
European Observatory on Health Systems and Polices and with the Personal Social 
Services Research Unit at the University of Kent, this paper examines trends and 
innovations in health and social care funding in a selection of high-income countries. We 
focus on where the money to pay for care comes from, not on how it is then spent. Drawing 
on a review of the literature and interviews with 30 key informants in nine countries, we 
explore current thinking on the options for funding health care and social care. Our aim is to 
add to the evidence base and improve the quality of the debate, rather than make 
recommendations. 
This paper is the first publication from the project. A subsequent paper will present findings 
from research into the preferences of the general public in England, Northern Ireland, 
Scotland and Wales for different ways of funding health care and social care. 
Specifically, in this paper we: 
• provide examples of funding configurations for health and social care, as well as 
changes that have been implemented, or are being considered, in a range of high-
income countries 
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• explore the drivers of recent or planned health and social care funding changes and 
reforms and the contexts within which decisions around funding were taken 
• highlight key points that can inform the range of conceivable options for funding 
health care and social care in the four countries of the UK. 
We report on each of these in turn. 
Most reviewed countries fund health care primarily from public sources, such as 
taxation and mandatory health insurance, but funding of social care often relies more 
than health care on individuals paying privately.  
In 2016, across most high-income countries reviewed in this report, government and 
mandatory health insurance schemes ranged from around two-thirds of total health care 
expenditure in Australia and Switzerland, to as much as 85% in Sweden, Japan and 
Germany. This compares with 79% in the UK. In the USA and South Korea – the two notable 
outliers in this review — around half of health expenditure was from public sources. Real 
public expenditure on health care per person increased between 2006 and 2016 (or the 
latest available year) in all reviewed countries, with the exception of Italy, which saw a small 
decline in spending. 
Social care also tends to have a significant publicly funded component in most reviewed 
countries, particularly for long-term care services deemed health-related. However, personal 
care services to assist people with activities of daily living often rely to a much greater extent 
on private funding, as is the case in all four UK countries. Furthermore, in some countries 
there has been a focus on constraining public expenditure on social care, which implies 
greater reliance on expenditure by care recipients themselves. Of note, we do not consider 
public expenditure on welfare payments to people living with disabilities, sometimes referred 
to as ‘disability benefits’, because these are transfer payments that supplement the income 
of the recipients rather than constituting funding for the provision of care per se. 
Differences between the two sectors in terms of funding sources may lead to seemingly 
arbitrary boundaries between health and social care within a country. While the integration of 
health care funding with social care funding is an acknowledged priority in some countries, 
this has tended to remain an aspiration in many settings with a few notable exceptions, for 
example, in the legislation of the planned health and social care reforms in Finland. 
Health and social care funding reforms tend to be incremental rather than radical, are 
path-dependent, and are catalysed by changes in economic conditions rather than by 
rising demand for care.  
Almost no country is engaged in radical reform of health care funding, but social care 
funding has been subject to more substantive change in a few countries. Concerns that 
prompt changes in, and reform of, funding often arise from economic crises, or perceived 
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crises, and associated public resource constraints. The ability to generate revenues, whether 
public or private, is inevitably dependent on the broader economy and in times of economic 
difficulty, a common policy response has been to try to limit public expenditure. Changes in 
taxes are often made as part of a wider tax reform programme and are typically not designed 
with increasing or protecting health or social care funding in mind. At the same time, 
countries may also reconsider how they generate resources to pay for health and social care 
in an effort to make resources sustainable or to raise additional revenues. Perhaps not 
surprisingly, political commitment and preferences, alongside a perceived understanding of 
what is publicly acceptable, shape whether and what changes in funding are considered in a 
given country.  
However, no funding system that we reviewed has been entirely unaffected by change, 
although changes tend to be incremental rather than radical. This is not to say that 
incremental change is not important. Indeed, in England the recently introduced Social Care 
Precept, allowing local government to increase council tax by up to 3% per year to pay for 
more social care, is just such an example of an important but incremental change.  
While incremental change to health and social care funding arrangements tends to be more 
common, there are nevertheless examples of more fundamental reform efforts, such as the 
introduction of mandatory long-term care insurance in Germany and Japan. But even in 
those instances, path dependency, societal values and country context are clearly key to 
shaping the options that are considered or implemented.  
High-income countries have taken diverse approaches to tackling the need to 
increase health and social care funding and there is no single optimal, or commonly 
preferred, solution to achieving sustainable revenues.  
Overall, we find – unsurprisingly – that the international evidence does not signpost a single 
best path to follow for funding health and social care, for the countries of the UK to follow.  
The reliance on public funding of health care remains strong across all reviewed countries, 
while social care funding has been at the core of the reform debate in several countries, 
perhaps more so than the financing of health care. This is reflected, at least in part, by the 
adoption of mandatory insurance arrangements for funding of (some) social care in a 
number of countries that originally operated, as the countries of the UK still do, ‘safety net’ or 
means-tested systems. These are France, Germany, Japan and Korea.  
Many countries raise taxes for health and/or social care at sub-national as well as national 
levels. Similarly, throughout the UK, local government contributes a small part of funding to 
the tax base for social care (via council tax, a form of tax based on house values, and 
business rates), although it does not raise funds for health care. To do so would be 
administratively complex and would require funding equalisation arrangements so that areas 
with more vulnerable populations and/or weaker local tax bases did not lose out. Our 
international review revealed no clear interest in either increasing the reliance on locally 
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raised taxes or, conversely, on greater centralisation at the level of national government. 
There are examples of movement in each of those directions. 
Among the reviewed countries there was little indication of active consideration of 
earmarking/hypothecation of taxes to fund health care or social care. Hard hypothecation – 
where funding is directly tied to the revenues raised by a specific tax that is not used to fund 
anything else – has not been used anywhere. This may be for a variety of reasons, including 
the unappealing pro-cyclical nature of relying on a single revenue source and the rigidity that 
hypothecated revenues introduce into balancing public expenditures across the full range of 
public services and welfare benefits. Hypothecation of any taxes to fund health and/or social 
care is not currently practised in the UK, although in the past an increase in the National 
Insurance contribution rate has been described as being dedicated to increasing NHS funds 
(i.e. soft hypothecation). There are near-precedents, such as the national television licence 
fee that is hypothecated to finance the British public service broadcaster BBC, though even 
the BBC does not rely in full on television licences for its income. National Insurance, paid 
for by workers and employers as a tax on income from employment, may be thought of by 
some as a hypothecated tax to fund the NHS, state pensions and welfare payments. 
However, revenue generated from national insurance contributions is not hypothecated in 
practice. 
There has been consideration of using other forms of hypothecated revenue generation to 
fund health (or social) care through so-called ‘sin taxes’. These are taxes levied on alcohol, 
cigarettes or sugary drinks. Sin taxes have some popularity but where they are being 
extended it is to encourage behaviour change, not to raise dedicated funds for health care 
and they tend to raise only relatively modest sums.   
In recognition of the likelihood that the baby boomer generation will put increased strain on 
the social care system in the future, the mandatory long-term care insurance programme in 
Germany is setting aside a small proportion of the funds it raises from monthly contributions 
for use from 2034 onwards. Such ‘pre-funding’ of future care is not in common practice. 
Among the countries we reviewed, only New Zealand has so far attempted anything similar, 
but that was to pre-fund future state pensions, rather than social care or health care, and 
payments into the fund have been suspended for several years now. 
There has been no major extension of user charges for health care in any of the countries 
we reviewed. But user charges remain a component of health care funding. They are a much 
greater source of funding for social care where means-tested charges are a common and 
continuing feature. A number of countries are considering (further) increases in these 
charges, recognising the potentially dampening effects on demand as well as the revenue 
implications. For health care, countries have in some cases reduced or abandoned specific 
cost-sharing arrangements, in part due to negative public reaction to charges and limited 
revenue generation from them. User charges in health care are contentious in the UK, too, 
Identifying options for funding the NHS and social care in the UK: international evidence 11 
and the devolved governments in Northern Ireland, Scotland and Wales have all taken the 
opportunity to abolish prescription charges.  
Mandatory insurance has long been the basis of funding health care in several of the 
countries we reviewed. More recently it has, as noted earlier, been extended into social care.  
By contrast, we found no increase in reliance on voluntary insurance as a source of either 
health care or social care funding. For social care, no country among those that we reviewed 
has made voluntary insurance work. Voluntary health insurance is present in many countries 
in a complementary (insuring against patient charges and co-payments) or supplementary 
(financing improved or greater access beyond publicly funded health services) role. It has a 
supplementary role in funding health care in the UK, more so in England than in the rest of 
the UK. 
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1. Introduction and background 
 
 
 
 
 
The demand for health and social care is rising and for good reasons. We are living longer 
and as a consequence the number of older people is growing rapidly. Coupled with the rising 
burden of multiple chronic disease and increasing frailty in old age, this means that the 
number of people needing support in their daily lives, through health and social care, is also 
rising. This comes alongside accelerated advances in medical technology and knowledge 
that provide significant potential for new methods of delivering and organising care. Demand 
for social care and health care is rising faster than the public funds that are available to 
spend on them in all four countries of the UK, leaving a large and growing funding gap. 
Clearly, the UK is not the only country facing these challenges and there is  potential to learn 
from the many experiences in other countries In this paper,  we seek to understand how 
other high-income countries have thought about and implemented changes to their funding 
systems to better meet the challenges ahead. 
This paper is part of a broader project funded by the Health Foundation, which aims to 
identify a range of feasible options for the future funding of health and social care in the four 
countries of the UK, and assess the relative (un-)attractiveness of different funding 
approaches to the general public. Conducted by RAND Europe, in collaboration with the 
European Observatory on Health Systems and Polices and with the Personal Social 
Services Research Unit at the University of Kent, this paper examines trends and 
innovations in health and social care funding in a number of high-income countries. We 
focus on where the money to pay for care is to come from, not on how it is then spent. Our 
intention is to add to the evidence base and improve the quality of the debate, rather than 
make recommendations. 
This Working Paper has been produced at an interim stage of the two-year research project. 
Drawing on a review of the literature and interviews with 30 key informants in nine counties, 
we identify current thinking in high-income countries internationally on the options for funding 
health care and social care. We build on existing descriptions of health and/or social care 
funding in high-income countries, with a particular focus on understanding the more salient 
issues around changes and reform in health and/or social care funding. We consider the 
diverse starting points in terms of existing funding arrangements and how different countries 
This section sets out: 
• the motivation behind, and scope of, the research project 
• key features of the current health and social care funding arrangements in the 
four UK countries 
• he structure of the rest of the Working Paper. 
Identifying options for funding the NHS and social care in the UK: international evidence 13 
have addressed the increasing demand for health and social care amid economic pressures. 
By examining what, if any, changes have been made to funding arrangements in countries 
that face challenges comparable to some of those in the UK, this paper seeks to stimulate 
further thinking to inform pivotal policy decisions about how health and social care are 
funded in the four countries of the UK.* A later Working Paper will then present findings from 
the discrete choice experiment and focus groups about the preferences of the general public 
in England, Northern Ireland, Scotland and Wales for different ways of funding health care 
and social care. 
In the present paper we:  
• provide examples of funding configurations for health and social care, focusing on the 
changes and adjustments to them that have been implemented, or are being 
considered, in a range of high-income countries 
• explore key drivers of recent or planned health and social care financing changes and 
reforms and the contexts within which decisions around funding were taken 
• highlight key points that can inform the range of conceivable options for funding health 
care and social care in the four countries of the UK in the future.  
We do not attempt to provide an exhaustive typology of countries according to how they fund 
health and social care. Such an attempt would be of limited practical use, as systems 
continue to evolve in response to challenges (ageing populations, the rising burden of 
chronic diseases, growing public expectations and technological advances), against a 
background of constrained financial and human resources and pressure for increased 
efficiency. Instead, we begin by identifying the key dimensions and features of health and 
social care financing systems in a range of high-income countries, building on existing 
literature. Specifically, we aim to focus on those dimensions where there has been a change 
over the last decade or so. 
We recognise the inherent complexity and interdependence of health and social care funding 
systems. There are many ways to characterise their key features and analyse the drivers 
and effects of changes. Health care funding arrangements have received greater attention in 
the academic and policy literature than social care funding. This is reflected, in part, in the 
much greater wealth of internationally comparable data on variables such as expenditure by 
source and trends over time, such as those compiled by the OECD. By comparison, any 
analysis of social care funding arrangements is more limited. Overall, we view the analysis 
presented in this paper as largely exploratory in nature, in particular with regard to issues 
that arise when funding of health care is compared with funding of social care. We hope that 
the paper will stimulate further discussion among stakeholders. 
Finally, it is important to emphasise that our focus is on the generation and collection of 
money to fund health and social care. We recognise the interdependency between how 
                                                
* Funding may not be the only binding constraint. There may also be constrained supplies of specialised 
resources such as particularly skilled labour. But our focus is on funding rather than any other constraints. 
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money is raised and how it is spent to deliver health and social care services, not least in 
those instances where care users are required to pay, in part or in full, for the services they 
receive. But it was beyond the scope of this work to examine how the funds are allocated to 
the provision of different care services.  
1.1 Background to the research 
How to raise funding to pay for health care has long been a subject of discussion in the UK, 
as elsewhere. Periodically ideas are put forward, and less often they are evaluated, with 
respect to changing the heavy reliance on general taxation that has characterised funding of 
NHS services in the UK since its inception in 1948. The pros and cons of tax funding versus 
mandatory health insurance and the arguments for changing the balance between public 
and private funding, both via private insurance and from out-of-pocket payments, have 
frequently been debated. However, the debate in the UK has often taken place without much 
consideration of details or learning from international contexts.  
More recently, growing attention has been given to options for funding social care, especially 
for long-term care of frail older people*, with a parallel debate emerging around the 
challenge of the largely historical separation of health care and social care funding, given 
that services can be seen to lie along a single spectrum of services aimed at improving 
people’s wellbeing. Boundaries between what may be thought of as ‘health care’ services or 
as ‘social care’ services exist de facto, largely as a result of the institutional and funding 
arrangements that have developed over time in the UK and (differently) in other countries. 
However, for practical purposes those boundaries are increasingly being questioned and 
attempts are being made to break them down altogether. 
In this Working Paper, we explicitly consider the funding of both health care and social care. 
We do not offer precise definitions of ‘health care’ or ‘social care’, as these vary in practical 
detail between countries and our concern is with how to pay for the whole spectrum of care. 
In the rest of the Working Paper, the term ‘health care’ can be thought of broadly as the 
range of services that are currently available from the NHS in all countries of the UK. The 
term ‘social care’ carries more or less the same meaning throughout the UK, although the 
specifics vary concerning who currently receives particular kinds of publicly funded social 
care services, as is described later. However, the term ‘social care’ is not in universal use 
across the countries we have studied. Within social care we focus on funding care for 
dependent adults, which in some jurisdictions is more commonly referred to as long-term 
care (LTC). Hence, in the remainder of the Working Paper, the terms ‘social care’ and ‘LTC’ 
can be thought of as interchangeable. 
  
                                                
* Social care of this kind as understood in the UK is often referred to as long-term care (LTC) in other countries. 
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1.2 Key features of health and social care funding in the four UK 
countries 
Health and social care are devolved policy areas in the UK, and therefore any discussion of 
their funding must be seen in the context of the UK’s devolution settlement of 1998. Northern 
Ireland, Scotland and Wales receive funding from the UK government in the form of block 
grants, the size of which is determined by the so-called ‘Barnett formula’. The principle of the 
arrangement is that any increase or reduction in public expenditure by the national 
government on health or social care (and some other areas of public expenditure) in 
England will then automatically feed through to a proportionate increase or reduction in 
public funding available to the devolved governments in Northern Ireland, Wales and 
Scotland.1 
Arrangements for funding health care are very similar across the four UK countries, although 
with differences in use of prescription charges (Box 1). Funding of social care is rather 
different than for health care, but the four UK countries fund social care similarly, although 
with important differences in how much money is levied by local authorities through user 
charges (Box 2).  
Questions of how to fund health care, social care, or both, have generally been considered 
in a context of demand rising faster than the resources made available to meet that demand. 
As the number of people with multiple chronic conditions grows, in the context of ageing 
populations and advances in technology, so does the demand for health and social care 
services – alongside an expectation that these should be of high quality and good value for 
money. Consequently, discussion of funding is often couched in terms of whether existing 
approaches can be expected to be sustainable under ever-growing demand pressures.2 
Whatever the rate at which demand for health and social care grows in the future, it is 
important to gather evidence as to which of the many funding options are the most publicly 
acceptable, and to identifythe most important factors that drive policy choices. 
1.3 Structure of the Working Paper 
The rest of the paper is structured as follows. Section 2 describes the methods and 
approach used. Section 3 presents a synthesis of patterns and trends in international care 
funding models. Section 4 sets out a wide range of reform initiatives along with specific case 
studies. Section 5 discusses key aspects of the funding environment that can drive or 
constrain reform. Section 6 concludes this first stage of the research project by summarising 
the key points from our analysis of current thinking internationally and its possible relevance 
in the countries of the UK. 
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Box 1: Funding health care in the UK: key points 
• Throughout the UK the National Health Service (NHS): 
o provides near-comprehensive health care to all UK residents, predominantly 
free of charge to the patient at the point of use 
o is 99% funded from general taxation at a UK level – that is, from the total ‘pot’ 
of UK government revenues from all taxes and other sources, including 
National Insurance contributions     
o is not paid for by any specific tax – in other words there is no “hypothecated” 
tax funding of the NHS 
o is not funded by local taxation 
o is 1% funded from patient charges, including prescription charges and dental 
fees 
 
• In the 2016-17 financial year, total UK government expenditure on the NHS (operating 
expenditure and capital expenditure combined) was £143.6 billion (source: HM 
Treasury3 Table A.11), which is equivalent to £2,187 per person. Government 
expenditure on the NHS ranged from £2,169 per person in England, to £2,233 in Wales, 
£2,240 in Northern Ireland and £2,332 per person in Scotland (source: HM Treasury3 
Table A.15) (all figures in this bullet point are in 2016-17 prices). 
 
• UK residents buy additional health care out of their own pockets, ranging from over-
the-counter (non-prescription) medicines to non-emergency surgical procedures 
 
• In 2016, 10.5% of UK residents were covered by additional, voluntary health insurance 
for non-emergency care in order to have the option of treatment at their convenience 
rather than having to join NHS waiting lists, or because they prefer to be treated in 
private facilities (source: LaingBuisson4) 
 
• The only significant differences among the four UK countries in how health care is 
funded is the presence or absence of charges for prescriptions dispensed outside 
hospital. Until 2007, prescription charges applied throughout the UK, but they were 
abolished in Wales in that year, in Northern Ireland in 2010 and in Scotland in 2011. 
Charges continue to be levied in England, and in the year 2017-18, £8.60 per 
prescription for the non-exempt population (meaning, essentially, that charges are paid 
only by adults aged 18-60, excluding full-time students, some people on low incomes, 
pregnant women, women within one year of childbirth, and people with certain specified 
health conditions). 
 
Identifying options for funding the NHS and social care in the UK: international evidence 17 
 
  
Box 2: Funding social care in the UK: key points 
• Unlike health care, funding for social care comes mostly from private sources. 
 
• Not only that, a large portion of social care is provided informally, by family and friends. 
Estimates from the National Audit Office (NAO) for England in 2014 showed that the 
informal care being provided was worth between £55-97 billion, which is much greater 
than the amount of public spending on social care.5 
 
• Local authorities (LAs) have the primary responsibility for public funding of social care 
in the UK, except in Northern Ireland, where five health and social care trusts (HSC) 
have this responsibility. In England in 2016-17 (source: Adult Social Care Statistics)6: 
o £14.8 billion was spent by LAs on adult social care (net current expenditure) 
o £2.4 billion was contributed by the NHS to social care. Although the NHS 
focuses on health care, it does contribute to some social care to improve health 
outcomes. 
 
• In England a Social Care Precept was introduced in 2016-17, allowing local 
government to increase council tax (a form of tax based on house values) by up to 3% 
per year to pay for more social care. 
 
• Northern Ireland, Scotland and Wales each receive a block grant from the UK 
government (determined by the ‘Barnett formula’) and have autonomy to decide how 
to spend their funds, which are then allocated to LAs and NHS organisations. Each 
country also has autonomy to set their own limits on the value of assets that a person 
can have while still qualifying for public funds. That ranges from £23,250 in England 
and Northern Ireland to £26,500 in Scotland and £30,000 in Wales (for care in Wales 
in a care home, though an asset limit of £24,000 applies in Wales for care in the 
recipient’s own home). 
 
• With the exception of Scotland, social care is not free of charge unless the recipient 
passes a means test. All countries have charges on residential care that vary by 
country and the recipient’s assessed income. 
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2. Data and methods 
 
 
 
 
Our approach consisted of two stages: a review of published evidence and key informant 
interviews. Our approach was pragmatic, seeking to capture key trends in a number of high-
income countries that we considered to be most useful in terms of health or social care 
funding from which the UK could potentially learn. We principally draw on published reviews 
of health and social care funding arrangements in high-income countries, supplemented by 
additional evidence as identified from ‘snowballing’ and interviews with key informants. We 
have benefitted from thorough review and discussion of our findings by the members of the 
Expert Reference Group (listed in Appendix A). We are therefore confident that the material 
presented and discussed in this paper is a good representation of the range of funding 
options available. 
2.1 Review of the published evidence 
We carried out a targeted review of the published and grey literature on health and social 
care funding in 15 high-income countries plus the UK. Country selection was informed 
mainly by relevance to the UK context in terms of comparability to the UK regarding both 
short- and long-term challenges. A key criterion was that countries should exhibit some 
variety and change in funding arrangements for health and/or social care, with evidence of 
active consideration of reforms affecting the sources of funding for health care and/or social 
care in the past two decades. It was beyond the scope of this work to carry out a 
comprehensive assessment of the available literature, given the large number of countries 
we wished to review. Rather, we drew on the considerable collective experience of the 
research team (the authors of this report) to identify literature likely to provide the required 
information about health and social care funding options, and reforms to those, among high-
income countries. As a starting point, we used detailed country reviews from the Health 
Systems in Transition (HiT) series* and the Assessing Needs of Care in European Nations 
(ANCIEN) reports,† as well as existing overviews of health care and/or social care 
arrangements in various high-income countries. Additional literature was sourced from a 
targeted search of documented assessments of identified reforms in the reviewed countries 
                                                
* All Health Systems in Transition (HiT) reports can be found on the website of the European Observatory on 
Health Systems and Policies: http://www.euro.who.int/en/about-us/partners/observatory/publications/health-
system-reviews-hits/full-list-of-country-hits, accessed most recently on 10 May 2018. There are many HiT reports, 
and they are only cited in this Working Paper where we refer to information from specific individual reports. 
† Available at: https://cordis.europa.eu/project/rcn/90930_en.html, accessed most recently on 16 May 2018. 
This section describes how we obtained information on funding arrangements (and 
changes to them) internationally, via two main routes: 
• review of published literature 
• interviews with key informants internationally 
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(using PubMed and Google Scholar) and of governmental and non-governmental agencies 
and organisations with a remit in the area of health care and/or social care in each country.  
We developed an analytical framework to guide the review of each individual country. 
Information for each country was extracted into a spreadsheet, using a common format. The 
table template is too large to present in this document but its structure was based on an 
analytical framework described in Appendix B. This enabled structured assessment of the 
key configuration choices and recent trends related to revenue collection and financing, 
coverage and benefits, and cost-sharing arrangements in the reviewed countries.  
 
Table 1: Countries included in this review 
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2.2 Key informant interviews 
Literature review findings were discussed in a workshop meeting with the Expert Reference 
Group (Appendix A) in order to test the findings for relevance to the UK context and identify 
comparator countries of particular interest in respect of health care and/or social care 
funding arrangements and policy discussions around those. This informed the selection of a 
sub-sample of nine countries out of the 15 for further in-depth analysis, using interviews with 
key informants in the identified countries to gain better understanding of current thinking 
about options for reforming health and social care financing systems and the contexts within 
which reforms have been implemented or considered. 
Key informants were identified through a combination of purposive and ‘snowball’ strategies 
using the published literature, official websites, the authors’ professional networks and 
recommendations from other study participants. We focused on a range of stakeholders 
involved in the organisation, governance or delivery of health services, considering 
representatives of ministries responsible for health and/or social care, or of local 
government, representatives of medical associations, associations of social security 
institutions or associations of insurance funds (policy stakeholders) as well as experts from 
universities and research institutes (‘academic’ stakeholders). 
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Potential study participants were invited to participate by e-mail and provided with 
background information. Interviews were semi-structured, using an interview topic guide. 
They explored reform(s) and the drivers behind them, perceived impacts of past or ongoing 
reforms, the roles of different forms of funding sources, and measures to ensure medium- 
and long-term sustainability of health and social care funding. The interview topic guide, 
which was shared with participants before the interview, is presented in Appendix C. 
Interviews were conducted by telephone and lasted between 30-60 minutes. Most interviews 
were conducted in English, but a small number were conducted in French or German at the 
request of the interview participant. Interviews were audio-recorded with permission, 
translated where appropriate and transcribed verbatim for ease of reference and to ensure 
accuracy in understanding the points made.  
We conducted a total of 30 interviews in nine countries (Tables 1 and 2) during the period 
December 2016 – February 2017.* Interviews were undertaken by one researcher in each 
case. The transcripts were shared with the other members of the research team and key 
points noted concerning funding arrangements. These were then discussed and agreed 
among the research team, with reference back to the source transcript where necessary to 
ensure clarity. 
As noted, the main purpose of key informant interviews was to gather additional insight into 
some of the more salient characteristics of health and/or social care funding, including 
drivers behind changes and perceived impacts. As such, they served to provide additional 
factual information and data were organised according to pre-defined topics. Interview data 
were incorporated into the evidence review, with direct quotes serving to illustrate a given 
aspect of interest. In the text, we label these by country and stakeholder affiliation (eg New 
Zealand policy NZ_1). Data reported here represent reviewed countries’ policy context as of 
March 2017. 
As the project required interviews from professional and academic specialists, the project 
proposal was submitted to the Research Ethics and Governance Ethics Panel of the 
University of Kent School of Social Policy, Sociology and Social Research, where it received 
approval in December 2016. 
 
  
                                                
* We approached a total of 69 people for interviews, of whom 27 did not reply after the initial contact and a 
reminder, and 13 declined to be interviewed themselves but passed us to alternate interviewees (who are 
counted within the total of 69 approached).  
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Table 2: Key informants interviewed  
Country Area Policy Academic Total 
Austria Health care, 
social care 
2 2 4 
Finland Health care, 
social care 
- 3 3 
France Health care, 
social care 
1 2 3 
Germany Health care, 
social care 
5* 2 7 
Italy Social care - 1 1 
Japan Social care - 1 1 
The Netherlands Health care, 
social care 
2 4 6 
New Zealand Health care 1 - 1 
Sweden Health care, 
social care 
3 1 4 
Total  14 16 30 
Note: * includes one interview with two key informants participating 
 
2.3 Case studies of selected funding approaches or trends 
Taken together, the literature review and interviews yielded a rich set of information from 
numerous countries. In discussion with the Expert Reference Group, we identified five areas 
where more detailed information in the form of case studies was desirable in order to make 
clearer the practicalities of what lies behind the ‘headline’ funding approach. These were: the 
introduction of mandatory long-term care insurance in Germany; the history of repeated 
political interventions leading to frequent changes to the payments required under 
mandatory health insurance in Germany; the various forms of tax hypothecation, particularly 
as used in France and Italy; how local income taxation works, using the Finnish example; 
and evidence for the impact of user charges, particularly on access to health care.   
Case studies drew on additional reviews of the published evidence and, where appropriate, 
the aforementioned key informant interviews. 
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3. Funding of health and social care in 
15 high-income countries 
 
 
 
 
In this section we describe configurations for the funding of health and social care in 15 
countries. The findings presented in this section are drawn mainly from the literature review, 
supplemented by what we learned in the interviews. We review published data on health and 
social care funding from public and private sources respectively, and explore how these 
have evolved over time. As noted earlier, there is a greater wealth of internationally 
comparable data on funding configuration and trends in health care, and this is reflected in 
the data presented here.  
We start by setting out the main approaches to funding either health care or social care 
implemented in the 15 reviewed countries, noting that countries typically use a blend of 
different sources. With this in mind, we review the current balance of public and private 
funding of health care and in social care in those countries and whether that is changing.  
3.1 The main funding arrangements in place in high-income 
countries 
The following is the range of funding options for health care or social care (see Mossialos 
and Dixon7 for a similar structure in the specific context of health care): 
• taxation, which may be paid by individuals or companies, and may include: 
o direct taxes – on incomes or wealth, eg income tax, corporation tax, council 
tax, inheritance tax 
o indirect taxes – on what people buy, eg VAT, petrol duty, excise duties, stamp 
duty 
and may be collected at various levels of jurisdiction: 
• nationally 
• sub-nationally. 
Taxes may either be put into a general pot for funding all areas of public spending 
(including defence, foreign aid, and so on) or they may be earmarked (or 
‘hypothecated’) to be spent only on health care or social care (or both). 
 
This section sets out: 
• how health care and social care are funded in practice in a range of high-
income countries 
• the balance between public and private funding of health care and social care 
and whether that is changing 
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• mandatory insurance, which may be collected by a government body (national or sub-
national) or one or more independent public bodies (eg social insurance funds) or 
private companies, whether not-for-profit organisations or for-profit commercial 
enterprises. Mandatory insurance is usually collected as a levy on earnings from 
employment, with both employee and employer contributing 
• voluntary insurance, usually collected by private companies (for-profit or not-for-profit) 
• out-of-pocket payments, which means that individuals pay for the care they want when 
they need it, but if they cannot afford the price then they have to go without the care. 
A further type of funding option is known as ‘medical savings accounts’, where an individual 
pays in over time (in a similar way to paying for a pension) but what they may take out of the 
account to pay for care is limited to what they have paid into it, the consequence of which is 
that medical savings accounts are invariably accompanied by voluntary insurance. Thus 
medical savings accounts can be seen as a combination of out-of-pocket expenditure with 
voluntary insurance, rather than as an additional, distinct option for care. Hitherto, medical 
savings accounts have only been used to a significant degree in Singapore (for health care, 
not social care) – a country whose population is characterised by an exceptionally high 
propensity to save, much higher than in the UK. 
Thus, in the remainder of this Working Paper, we will be discussing options for funding 
health care and/or social care in terms of the list set out above. Appendix D describes how 
entitlement to publicly funded care services, and the range of services to which people are 
entitled, varies across the high-income countries we reviewed. 
3.2 The balance between public and private funding of health care 
In most of the reviewed countries, expenditure on health is largely funded from public 
sources, such as taxation and mandatory health insurance.* In 2016, across most high-
income countries reviewed in this report, government and mandatory health insurance 
schemes accounted for between two-thirds of current health expenditure in Australia and 
Switzerland, to around 85% in Sweden, Japan and Germany (Figure 1). This compares with 
79% in the UK. In the USA and South Korea – the two notable outliers in this review— only 
about half of total health expenditure was considered to be from public sources, at 49% and 
56%, respectively, with the remainder from private sources.  
 
                                                
* Sources of revenues of financing schemes are notoriously difficult to quantify. The System of Health Accounts 
(SHA) (see OECD, Eurostat and WHO)8 provides the basis for capturing revenues of financing schemes, but in 
practice this data is currently not reflected in the OECD database. For example, where we refer to expenditures 
in systems operating mandatory health insurance schemes, some portion of this expenditure is from general 
government revenues (i.e. taxation), which is transferred to insurance schemes. Similarly, private and voluntary 
health insurance schemes are at times difficult to disentangle. We comment on these issues where relevant. 
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Figure 1: Per capita expenditure on health (US$ purchasing power parity) by principal 
source in 14 OECD countries, 2016 
 
Source: OECD9  
 
Commentators frequently distinguish government tax-funded systems and mandatory 
(sometimes referred to as statutory, compulsory or social) health insurance systems, 
although in reality many countries draw on a combination of these and other resources. Half 
of the countries considered here are predominantly funded through taxation (sometimes 
referred to as ‘government’, see also Figure 2) (Australia, Canada, Finland, Italy, New 
Zealand, Sweden, UK), accounting for between 61% of total health expenditure in Finland 
and 67% in Australia to 79% in the UK and 84% in Sweden. France, Germany, Japan and 
the Netherlands are mainly financed through mandatory contributory health insurance, 
which, in 2016, accounted for between 75% of total health expenditure in France and 78% in 
Germany. Mandatory contributory health insurance schemes also constitute a substantial 
component of health financing in South Korea (46%) and Switzerland (42%).  
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Figure 1: Public funding sources – government tax funding and mandatory 
contributory health insurance – as a proportion of total health expenditure in 14 OECD 
countries, 2016 or most recent year for which data available* 
 
* 2015 for France, Germany, Switzerland, US, UK and Sweden; 2014 for Japan and Australia; 2013 for New 
Zealand 
Source: OECD9  
 
Government tax revenues can come from a multitude of sources, which may or may not be 
earmarked for health. Sources include income, property, corporate and consumption taxes. 
Depending on the system, taxes may be collected (and set) at central, regional or local 
levels, or a combination of these. For example, in Finland the health care system has 
historically been financed by a mix of central government and municipal taxes largely based 
on income; however, revenues generated through the national social security institution 
(Kela) have also played a role. In Sweden, the health care system is financed mostly through 
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and income taxes.* Central government resources are allocated to county councils and 
municipalities, or even selected organisations, to support particular objectives identified at 
national level. 
The health system in New Zealand is financed primarily through central government 
revenues, drawing on personal income, corporate and value-added taxes (goods and 
services tax, GST), with additional revenues coming from the government-operated Accident 
Compensation Corporation (ACC), a form of compulsory social insurance paid by employers 
and employees to meet the health care costs of accidents and injuries.10 Taxes are collected 
at central, local and regional levels, the latter in the form of property taxes, but local funding 
plays a very minor role in health care financing (under 1% of total public health care 
expenditure).  
In countries that rely to a large extent on mandatory insurance schemes to fund health care, 
insurance contributions are typically linked to earnings from employment. In France, 
individuals and their families are affiliated with one of the three insurance schemes based on 
their employment status. The majority (some 90% of the population) are covered by the 
general scheme (Caisse Nationale de l'Assurance Maladie des Travailleurs Salariés, 
CNAMTS). This covers all employees and their dependants and also includes non-working 
people eligible for universal basic coverage (Couverture Maladie Universelle, CMU).11 For 
those not covered through one of the obligatory SHI schemes on an employment basis, the 
CMU Act offers coverage to individuals who legitimately reside in France. CMU coverage is 
free for individuals in low-income households, but other beneficiaries must pay an annual 
premium equal to 8% of income above the ceiling (€9,534 in 2013–14). The third scheme is 
for transitory foreigners and undocumented migrants who have resided in France for at least 
three months: for them, the state medical assistance programme (Aide Médicale d'État, 
AME) provides free access to medical care if their incomes are below the CMU ceiling.11 The 
latter two schemes are funded as part of the national government’s budget, which accounts 
for 4% of total health spending. The CMU Fund is mostly financed by an earmarked 
premium tax on voluntary health insurance (VHI) contracts (€2.1bn in 2014).11 Overall, 
nearly 20% of statutory health insurance (SHI) revenue in France comes from state 
subsidies and earmarked taxes (eg on tobacco). 
In Germany, employees whose (gross) wages are lower than a (legally defined) income 
threshold are required to enrol with statutory health insurance (SHI), while those with higher 
incomes may purchase private health insurance.12 Non-earning dependants of SHI members 
are covered free of charge by the sickness funds. That is: the contributions to the sickness 
funds (plus a subsidy from government general tax revenues) are centrally pooled and then 
reallocated to the sickness funds based on a risk adjustment formula. All contributors to the 
sickness funds and their (non-contributing) dependants are covered by this funding. In 2015, 
                                                
* County councils and municipalities also receive state grants, which are financed through national income taxes 
and indirect taxes, and are designed to contribute to equalisation across local government areas with different tax 
bases and different spending needs. 
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about 86% of the population were covered by SHI, 11% by substitutive private health 
insurance (PHI), while the remainder (soldiers, police) were covered under special 
programmes. Taxes play a modest role in financing SHI in Germany at around 5%-10% of 
the total cost. General tax revenues at national, regional and local levels are used, among 
other purposes, to cover the costs of health care for recipients of social welfare, who are not 
insured elsewhere (and who then have to choose an SHI fund), as well as to subsidise a 
range of benefits paid for through SHI. These include maternity benefits, sick pay for parents 
caring for sick children, in vitro fertilisation, prescription-only contraception up to the age of 
21, and legal abortions.12  
In the Netherlands, mandatory health insurance accounts for 71% of total health care 
expenditure (Figure 2). Health insurers are 50% financed through a community-rated 
premium (that is, a premium that is the same for everyone and does not vary according to 
the health or other circumstances of the insured person) and 50% through an income-related 
employer contribution (paid to the tax office).13 
In both Japan and Korea, general tax revenues subsidise the respective national health 
insurance schemes and in Korea, fully finance the medical aid programme (MAP) for the 
very poor.14,15 
The USA is the only country among those reviewed where private health insurance (PHI)* 
constitutes a significant part of health system financing, at 40% in 2015 (Figure 3), along 
with public insurance schemes such as Medicare for people aged 65 and older and Medicaid 
for those who meet means-testing criteria. However, even in the USA, where insurance 
coverage has been made mandatory under the 2010 Affordable Care Act and where some 
PHI is tax-subsidised, the line between whether this revenue source should be considered 
public or private is blurred.  
 
                                                
* OECD data categorises this expenditure as ’voluntary’. 
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Figure 2: Private funding sources as a proportion of total health expenditure in 14 
OECD countries, 2016 or most recent year for which data available* 
 
* 2015 for Japan, UK, France and US; 2014 for Australia; 2013 for New Zealand 
Source: OECD9 
 
VHI forms a fairly important component in health system funding in Australia, Canada and 
France, at 13-15%, while elsewhere VHI accounts for a smaller proportion of health 
expenditure, at 1-3% in Germany*, Italy, Japan and Sweden; less than 6% in the UK; and up 
to nearly 8% in New Zealand and Switzerland.9   
Household out-of-pocket expenditure† plays a role in all health systems reviewed here, 
ranging from 7% of health expenditure in France; to around 11-15% in several countries, 
including the UK; and up to 37% in Korea (Figure 3).  
                                                
* From 2009, when health insurance was made mandatory in Germany, OECD data categorise substitutive 
voluntary health insurance, which was previously considered under the category of ‘voluntary health care 
payment scheme’, as a ‘mandatory contributory health insurance scheme’, which explains the sudden drop in the 
former as a proportion of total health expenditure, from 9.5% in 2008 to 2.2% in 2009 and, respectively, the 
increase in the latter from 69.5% in 2008 to 77.1% in 2009. 
† Out-of-pocket expenditure by households typically comprises direct spending by households after deducting 
third-party payments such as insurance. Thus it includes direct purchases by private households of care services, 
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Total health care expenditure has grown in per capita terms over the decade 2006-2016 
everywhere except Italy. In most countries, including the UK, total and public expenditure on 
health grew at similar rates over this period, meaning that the public/private mix of health 
care expenditure remained largely unchanged. However, in Switzerland and the USA, public 
expenditure on health care grew rather faster than private expenditure 2006-2016.  
3.3 The balance between public and private funding of social care 
For social care, countries included in the review also have a significant publicly funded 
component, although more stringent needs- and means-testing generally means that a lower 
proportion of all social care spending is (directly) publicly funded in most of these countries 
compared to health care spending. The levels of expenditure and funding discussed here 
exclude any public expenditure on welfare payments to people living with disabilities, 
sometimes referred to as ‘disability benefits’ – because these are transfer payments that 
supplement the income of the recipients rather than constituting funding for the provision of 
care per se. 
Unfortunately, measuring social care, or long-term care (LTC), as it is often referred to in 
international discussions, is not straightforward. There are two components to it: services of 
long-term health care and social services of long-term care.16 The health care component 
includes either medical or core personal care services to assist individuals with activities of 
daily living (ADL*) such as palliative care or health services in support of family care. The 
social care component provides assistance with instrumental activities of daily living (IADL) 
such as preparing meals, housework and household management. But these definitions are 
not completely clear cut. Each country has its own accounting system. These systems have 
been reviewed by the WHO, OECD and Eurostat so that there is more comparability 
between countries with regards to measured total expenditure in LTC and its share of GDP 
and total health expenditure. But statistics regarding LTC expenditure and financing are 
currently scarce. Nevertheless, Figure 4 provides some insights, but only for the health 
component of LTC. This component is largely dominated by public funding, with the 
Netherlands and France providing almost all of LTC health funding through public sources.  
                                                
plus any co-payments they are required to make for services that are otherwise paid for out of insurance or from 
taxation. 
* Activities of daily living (ADL) include bathing, dressing, eating, getting in and out of bed or chair, moving around 
and using the bathroom. Often they are referred to as ‘personal care’.16 
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Figure 4: Per capita expenditure on LTC (health component - US$ purchasing power 
parity) by principal source in 14 OECD countries, 2016 or most recent year for which 
data available* 
 
* 2015 for US, France, Germany, UK, Switzerland and Sweden; 2014 for Australia and Japan; 2007 for New 
Zealand 
Source: OECD9  
 
It is, however, necessary to take into account the social services component of LTC as well, 
in order to see a complete and accurate picture. In that component of LTC, private 
contributions play a larger role. But internationally comparable data for the social services 
component of LTC are not currently available. 
A wide variety of methods of funding social care are used across the countries we reviewed. 
In countries operating ‘safety net’ means-tested arrangements, financing for that is 
commonly part of the general tax revenue system, with funding allocated to social care on a 
budgetconstrained basis, rather than as an entitlement. Countries such as Australia, Austria, 
Ireland, Sweden, Finland, the UK and the USA all rely on general taxation collected either 
locally, regionally or nationally.  
For example, Austria has a large portion of its LTC system funded by the national 
government as opposed to municipalities and regions,17 whereas the Nordic comprehensive 
systems rely heavily on local tax revenues (albeit with central government grants). In 
Sweden, more than 80% of funding comes from municipal taxation.18 Similar arrangements 
work in Finland. However, as is discussed later, both these countries are undergoing a 
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centralisation reform of their financing systems, moving responsibility from municipalities to 
regional bodies.19,20 In the USA, the Medicaid system that supports long-term care for those 
on low incomes is a state-managed system, paid for with both state and federal tax 
revenues. 
By contrast, social insurance systems rely largely on mandatory contributions. In Germany, 
contributions are mandatory for all ages, with working adults and employers making a 
contribution; people without children pay a slightly higher rate than those with children (who 
might be expected to provide some informal care for their parents). Pensioners are required 
to pay at the same rate from their pension income. In Japan, financing is through a 
combination of a payroll tax for people over the age of 40, pensioner contributions and 
general taxation. In Korea, the LTC insurance system is funded by an LTC contribution rate 
equal to 6.55% of the National Health Insurance contribution. This value went up from the 
original 4.05% in 2008. It accounts for 60-65% of total LTC insurance expenditure. General 
non-earmarked taxation also funds the system through government subsidy of roughly 20% 
of total LTC expenditure, and the rest is covered by public insurance contributions.21 Japan 
also has a mixed system, with general taxation constituting 40-45% of social care funds and 
the remainder covered by co-payments (10% or 20% of service cost, depending on income) 
and payroll tax premiums.  
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4. What can the UK learn from how 
other countries generate funding for 
health and social care?  
 
 
 
 
 
 
 
 
To better understand the options available to the UK for reforming health and social care 
funding, Section 4 examines reform initiatives in selected high-income countries. We have 
also explored the extent to which countries have considered particular policy options related 
to revenue generation, even if they have not (yet, at least) implemented them.  
We begin by considering the mix of national versus local taxation. Sub-national taxation is 
already a feature of the funding landscape throughout the UK for social care – where 
revenues raised by local authorities are an important part of the total funding picture – but 
not hitherto for health care. Several other countries have broader experience of local 
taxation, for health care as well as social care, and in section 4.1 we discuss the case of 
Finland in a case study. 
We consider in section 4.2 a topic that recurs in the debate in the UK, particularly in the 
context of funding health care; namely, the idea of hypothecating (earmarking) specific taxes 
as raising funds solely for health care. 
We then take a detailed look at the option of mandatory insurance. While the UK relies 
exclusively on general taxation for public funding of both health care and social care, it is still 
worth exploring and debating whether there should be a role for social insurance schemes 
(meaning mandatory insurance) to replace or supplement tax funding. We look first at the 
possibility of introducing mandatory insurance for long-term care (LTC), i.e. social care, 
using a detailed case study of the German long-term care insurance (LTCI) system as our 
guide (section 4.3) and then considering the political implications of mandatory insurance 
(section 4.4). 
As described earlier, voluntary insurance plays some role in health care funding in many 
countries and a minor role in funding social care in a small number of places. But only in the 
This section sets out the main findings from the interviews with international 
experts, the review of literature and detailed case studies, and covers: 
• sub-national taxation, with Finland as a case study 
• hypothecation (earmarking) of specific taxes to fund health care 
• the option of mandatory insurance for long-term care (LTC), with a case study 
of the German long-term care insurance (LTCI) system 
• the inevitability of political intervention in funding arrangements, with a case 
study of mandatory health insurance in Germany 
• the role of voluntary insurance 
• the role and impact of user charges 
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USA is it a major source of funding for health care and nowhere is that the case for social 
care. We discuss the role of voluntary insurance in section 4.5. 
Finally, no discussion of ways to pay for care would be complete without considering the role 
of user charges. These are rather more controversial when talking of health care than social 
care – out-of-pocket payments have always been a major source of funds for social care in 
every country we reviewed as well as throughout the UK. We therefore focus the discussion 
of user charges in section 4.6 mainly on evidence about their impact in the more 
controversial role they play in health care. 
4.1 Local taxes or national taxes? Case study: local taxation in 
Finland 
A key question for public finance concerns the optimal mix of taxes. In this sense, optimal 
can be considered the most stable, able to generate sufficient revenues, but also the most 
equitable.22 Income and wealth taxes make up a significant portion of government revenues 
in EU countries, on average just under one-third of total tax and social contributions in 
2015.23 However, there is important variation in terms of whether those revenues are 
generated at local or national government levels. There is variation across reviewed 
countries in the extent to which sub-national levels of government are permitted to generate 
their own tax revenues, as well as the extent to which this plays a role in health and social 
care financing. Sweden and Finland have historically relied most heavily on local income and 
wealth taxes; in 2015, 70.1% and 62.7% of income and wealth taxes were generated at the 
municipal level in those countries, respectively (Figure 5). Throughout the UK, local 
authorities have a major role in public funding of social care, although not currently NHS 
care. 
In Sweden, for example, revenues are generated from income taxes that are levied and set 
by county councils and municipalities and supplemented by grants from the national 
government to ensure equity and to compensate for variability in revenue generation across 
regions.24 This means the responsibility for ensuring adequate financing involves a complex 
set of political, feasibility and technical considerations between two levels of government, 
local and national. A revenue equalisation scheme is in place aimed at enabling the different 
local authorities to offer an equal level of services across the country.19 The fairness of the 
equalisation scheme is reviewed on a regular basis by a committee appointed by the 
national government and the scheme is adjusted accordingly. The direction of adjustments 
is, however, influenced by the government in power, with recent experiences finding 
changes made by the previous government being reversed under the current government 
(information from interviewee Sweden Policy SE_1). Key informants interviewed for this 
study noted that there have been proposals to centralise health care and divide the country 
into just six regions rather than the current 21 counties, but no decision had yet (at the time 
of writing, in early 2018) been reached on this (Sweden Policy SE_3). However, while this 
was seen to change the tax base, it was not expected that it would fundamentally change 
the principles of the structure or the way taxation is being implemented. 
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Figure 5: General, central and local government tax receipts from income and wealth, 
selected countries, 2015 
 
Note: Countries sorted from left to right according to the share of public revenues generated from local 
government taxes. State taxes are an important source of revenues in some countries, such as Germany; they 
are not shown in the figure above. 
Source: Eurostat23 
 
In Australia, until recently, public funding of LTC was at state level, rather than being a 
national ‘Commonwealth’ (i.e. federal) responsibility. But since 2015, Australia has 
concentrated entry-level LTC funding and provision into a single institution: the 
Commonwealth Home Support Programme, organised by the Australian government’s 
department of health. Initial contact with public services and initial admittance into the LTC 
system are all handled by this national institution.25 
Why might a country choose local versus national income taxes? 
There are a number of possible reasons for choosing between local and centralised national 
income tax administration.26 In practice, the locus of tax administration is often linked to the 
locus of expenditure and accountability. That is, if local governments are responsible for 
collecting or generating a large share of tax revenues, it is typically because they are also 
responsible for a large share of government expenditure. Local control over revenue 
generation creates an accountability mechanism in places where collection (and use) of 
public resources is arguably more visible to local constituents. 
Locally generated income taxes may also appear favourable if there is interest in allowing 
flexibility; for example, in setting local tax rates. This could be to accommodate tax 
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preferences of the local population or to generate additional, needed revenues for use at a 
local level. Centralised tax administrations may alternatively be preferred because they are 
usually able to collect revenues at lower cost than local governments (unless local 
governments are quite large) since they can benefit from economies of scale of tax 
administration. 
In all countries, at least some funding of care is national; this includes the countries referred 
to above. The issue then arises that a local decision to raise local taxes to fund higher levels 
of care runs the risk of being counteracted if central government reduces its contribution.  
Even in the case of local income taxes, it should be noted that often taxes are collected 
centrally and reallocated to localities; there is also typically some degree of national level 
pooling to ensure equity of resources across localities. This ensures that wealthy areas do 
not have low tax rates while poorer areas must have high tax rates to fund local programmes 
of an equivalent standard. 
How has local income taxation worked in Finland and what are the planned 
changes? 
According to the Finnish constitution, the right to tax is granted to the national government, 
the municipalities, and local Evangelical-Lutheran and Orthodox churches. Each municipal 
council sets its flat tax rate each year. Data from 2009 shows the average tax rate was 
18.6% of earned income (and estates of the deceased) but varied across municipalities from 
16.5% to 21%. Alternatively, national taxes on earned income are set according to a 
progressive tax scale, set by parliament each year (Ministry of Finance, 2009).27 As shown in 
Figure 1, in Finland the national government generates significantly less tax revenue from 
income and wealth than municipalities, although in total, the national government receives 
the majority of tax revenues (approximately 60% of total public revenues go to the national 
government). 
Each individual in Finland receives a single tax return form pre-completed by the tax 
administration and containing information on earnings submitted by employers and other 
payers of income; it is up to each individual to submit any corrections, if necessary. The form 
reports an individual’s municipality for taxation purposes, which factors into the tax 
calculation (see an example of a Finnish tax return at 
https://www.vero.fi/download/2016__Precompleted_tax_return/{FB5ABADF-330B-4172-
9E03-9314438EB48E}/10486). Municipal taxes are therefore collected by the national tax 
administration alongside national taxes and subsequently paid to the municipalities. 
To reduce disparities among municipalities resulting from their differing tax bases and hence 
ability to raise revenues, a tax equalisation system is in place. Essentially, municipalities that 
are unable to raise tax revenues per inhabitant that are commensurate with the average 
municipality (i.e. those municipalities that fall below 90% of the country average) receive 
transfers from wealthier municipalities. Poorer areas may receive a large transfer of funds in 
this way. Wealthy municipalities contribute a maximum of 15% of their tax revenue to the 
equalisation system. Similar approaches that pool and reallocate resources according to 
differential risk across purchasers exist not only in predominantly tax-funded systems, but 
also in systems with mandatory insurance funds, such as Germany (Box 3). 
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Box 3: Centralised or decentralised revenue collection: not only an issue of tax-
funded systems 
In Germany, until 2008, individual SHI funds could set their own contribution rates (within a 
legally defined framework). However, this changed with the 2007 health care reform, which 
introduced a uniform contribution rate to be set, initially, by the federal government (from 
2011 by law).12 The reform also introduced a central reallocation pool (Health Fund, 
Gesundheitsfonds) as a means to bundle and steer the SHI revenue streams and oversee 
risk-adjusted allocations to individual SHI funds. The reform further introduced the stipulation 
for those individual SHI funds unable to cover their expenditure from the allocations made by 
the central Health Fund, to impose an additional premium on their members. This additional 
premium (‘capitation fee’) was to be paid solely by employees and was meant to stimulate 
further competition between SHI funds, the idea being that SHI funds would seek to reduce 
their costs in order to not have to impose an additional rate and so risk losing members. It 
was noted that this stipulation led to problems for some SHI funds, especially those with 
higher risk members:  
‘At that point, there were some extreme reactions including termination of contracts. Two 
health insurance funds even went bust in 2011/2012... This set fee was a strong price signal. 
People were not willing to pay €8 more than they did with other providers. That price signal 
had been a goal of the… [federal] government at the time, and it had substantial effects’ 
(Germany Policy DE_5). 
 
However, in spite of the equalisation scheme, spending and capacity to raise revenues have 
been under increased pressures in many municipalities, in part due to demographic 
changes. There have been major efforts to encourage voluntary mergers of municipalities, 
with the notion that they will benefit from economies of scale. This has led to some reduction 
in the number of municipalities but there remain nearly 300 municipalities to date. Available 
evidence also suggests that municipal mergers did not successfully reduce public 
expenditures.28 
The reliance on locally generated income taxes in Finland is likely to change under major 
proposed reforms. According to the reform proposals, municipalities’ role and responsibilities 
will be dramatically reduced, particularly in the areas of health and social care, which will be 
financed and organised by 18 newly formed counties.29 Because municipalities will be 
responsible for fewer outlays, they will collect and receive less revenue.  
It is expected that these changes will simplify the current multi-source financing system: 
‘We do have in Finland [an] economic efficiency problem resulting from the fact that for 
Finns, there are multiple sources for both collecting and allocating the finances that also 
creates incentives that are not aligned with each other’ (Finland Policy FI_2). 
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Simplification is to be accomplished by reducing the levels of municipal taxes and national 
social security institution contributions and raising the national income tax, with 
approximately two-thirds of the current municipal tax rate being converted into a national 
income tax (Finland Policy FI_2). This is thought to be feasible because ‘the government 
gave a guarantee… a political pledge that the effective income tax rate for individuals is not 
going to increase due to the reform’ (Finland Policy FI_2). These changes in taxes were 
made as part of a wider tax reform programme and not in order to increase or protect 
funding of health and/or social care.  
In practice, it is expected that income tax rates will not change noticeably for individuals as a 
result of the shift, but rather, a considerable share of income tax generation will shift from 
municipalities to the central government. Perhaps surprisingly, anecdotal evidence suggests 
there has not been much unrest among municipal councils, even though they will receive 
lower revenues and have less control over expenditure in their local areas. This may be in 
recognition that some councils are truly unable to meet their constituents’ needs, although 
such a conclusion is highly speculative. 
Relevance to the UK 
Interest in locally collected taxes has taken shape in the UK recently, not least because of 
the adult social care precept, which was collected as part of council taxes beginning in 2016. 
These are locally collected property taxes which are earmarked for adult social care. It is left 
up to each council to decide whether to collect them and at what rate, up to a 3% increase in 
council tax rates. However, without an equalisation scheme in place, wealthy areas are able 
to collect higher tax revenues or to levy lower tax rates in order to raise the desired level of 
funding, relative to poorer areas. 
Decentralised income tax collection may make sense in a context where that same 
decentralised body is also responsible for expenditure; in this sense, local taxation acts as 
an accountability mechanism. In the NHS, however, the appropriateness of local income 
taxes (i.e. council-based income taxes) would be difficult to envisage since the geographical 
boundaries of the 326 billing authorities in England (i.e. councils) do not perfectly align with 
unique NHS clinical commissioning groups, who are the localised bodies responsible for 
paying for care. Additionally, based on the experience in Finland, any increase in the local 
income tax rate should be matched by a proportionate decrease in national income taxes, 
which may be unappealing from the perspective of the exchequer since the central 
government would receive fewer resources and therefore have less flexibility or discretion 
over how total public funds are allocated.   
4.2 Tax funding of care: would hypothecation help? 
Hypothecation is the earmarking of revenues from a particular tax or group of taxes for 
specific, explicit purposes. It is an approach to health care funding that has provoked 
continuous interest and debate in the UK and elsewhere; and it could in principle be 
considered for funding social care (or indeed for any other purpose of public expenditure). 
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The idea of a dedicated ‘health tax’ is raised, by politicians and academics alike, as a 
possible option for the future funding of the NHS. While few countries included in the 
international review undertaken for this study used hypothecated taxes of any form to fund 
health care, the idea of hypothecation has been considered in some places, such as Finland, 
and implemented to a small degree in Italy and France.  
Tax hypothecation can take a number of forms, and is usually classified as either ‘hard’ (or 
‘pure’ or ‘strong’) or ‘soft’ (or ‘weak’).30 Hard hypothecation of a health tax, for example, 
would link its revenue directly and uniquely to health care spending and, importantly, the 
quantity of funds available for health care would be limited to the revenues raised by that tax. 
On the other hand, with soft hypothecation the specified tax(es) would fund only part of the 
total public expenditure on healthcare, the rest being supplemented by other sources. 
Another use of the term soft hypothecation is as a synonym for ‘incremental’ hypothecation, 
which is where the additional revenues raised from tax increases are used to fund increased 
public expenditure on health and/or social care.  
Soft hypothecation allows governments to buffer health care funding from shocks and 
shortfalls, as deficits can be made up from general taxation revenue where needed to 
‘smooth’ funding availability. However, this weakens the principle of hypothecation: the level 
of funding becomes dependent on the extent of general tax funds made available by the 
government and no longer just on the funds raised by the hypothecated tax. This distinction 
between hard and soft hypothecation is key to the substance of arguments for and against.  
The television licence fee, which is used to fund public television, radio and internet 
broadcasting by the BBC, is arguably a practical example of a hard hypothecated tax in 
operation in the UK (although it is not paid by the small minority of the population who 
choose not to have a television); and hypothecation is commonly raised as an option to 
consider for future funding of the NHS. 
Below, the key debates in the literature are explored in relation to the benefits and 
disadvantages of hypothecation, including a discussion of international examples of 
hypothecating tax. Finally, a case study draws out some possible implications for the UK 
context.  
Arguments for hypothecation 
Transparency for the taxpayer, and thus potentially improved public acceptability and greater 
willingness to pay (higher) taxes, is generally seen as the key advantage offered by 
hypothecation over general taxation. Hypothecation is contrasted with the situation where 
citizens see their tax payments disappearing into an undifferentiated pot of government 
revenues, which they know will be spent on a wide variety of ends, some of which they may 
not support. It is thought that linking the tax more explicitly to spending can make health 
funding potentially less vulnerable to political manipulation and fluctuation between 
budgets7,31,32 and may make people feel more ‘connected’ to their tax contribution. This in 
turn could increase pressure on providers to satisfy patients’ expectations and improve 
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service quality.33 Proponents also argue that this transparency and connectedness may 
make people willing to pay more tax34 and would allow voters to directly signal this 
willingness, along with their desire to see more spending on health.32,35 
Arguments against hypothecation 
On the other hand, arguments against hypothecation cite a number of possible 
disadvantages. While hard hypothecation may be said to introduce stability into health 
funding by protecting against political whims, the same mechanism can also create an 
unhelpful budgetary rigidity, where spending is determined by revenue generated rather than 
policy decisions informed by need or demand.7 This lack of flexibility to adjust spending 
according to changing priorities is a key drawback that dissuades many finance ministries, 
including in the UK, from favouring hypothecated taxation.36 Furthermore, earmarked 
revenues may not lead to increases in the total resources available for health and social care 
if budget allocations from other funding sources, such as general tax revenues, are 
commensurately reduced. 
In a reversal of the argument made above for hypothecation improving willingness to pay, 
there are concerns that, faced with a more distinct sense of their contribution to health care 
spending, social solidarity could be undermined by people increasingly pressing to be 
allowed to ‘opt out’ of a health tax, for example, if they hold private health insurance.37 
Others cite concerns that separating health care from other areas of public spending could 
lead to calls for earmarking in other areas, and work against the widely accepted good 
practice of integrated thinking around policies for population health.38  
Managing the challenge of macroeconomic fluctuation  
A key disadvantage of hypothecation is widely considered to be the susceptibility of 
earmarked taxes to fluctuations and cycles that are harder to smooth out than are general 
tax revenues, and the resultant greater instability in revenue streams. Thus, in order for hard 
hypothecation (where the hypothecated tax is the sole revenue source for a specific 
purpose) to be viable, the tax source would have to be large, steady and ideally growing at 
least proportionally to demand for the expenditure area. The latter is required in order to 
avoid continually rising rates of taxation to match the upward trend in demand for health 
care. It may be difficult, however, to make the argument for such an attractive source of 
revenue to be rigidly assigned to a single purpose.39  
Some have argued that some form of stabilisation fund is needed to smooth fluctuations: 
extra revenue would be deposited in the fund during good years, which would be used to 
supplement funding during downturns. However, without strict laws in place to prevent 
governments from redirecting surpluses in times of buoyant revenues or adding to the 
stabilisation fund from general taxation revenues, this would ‘soften’ the principles of 
hypothecation and weaken the benefits of transparency and trust.34,37,40,41 Such ‘soft’ 
hypothecation would be primarily a superficial exercise, whose only clear strength would be 
its potential to increase support for a tax rise if persuasively communicated to the public.37 In 
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addition, as the Barker Commission outlined, the expectation of a surplus in health spending 
in boom years may be misguided, as demand for health care is widely regarded as being 
income-elastic so that demand for health care expenditure rises more than proportionally 
with GDP.37,40,41 Resulting pressure on the government to spend more during boom years 
would negate any benefits of a stabilisation fund. To prevent this, the Barker Commission 
suggested the appointment of an independent body to stabilise spending by deciding how 
much should be dedicated to health care in any given year.41 
Some tax hypothecation exists in Italy and France 
Among the countries included in the review, we find that earmarking tax revenues for health 
care or social care is not common, although some countries have considered it. In our 
interviews it was noted that in Finland, discussions about the best way to fund health care 
and the option, in that context, to earmark funding have been ongoing for some time: 
‘We did consider [earmarking] – in fact, this is the third or fourth consecutive government 
which is trying to push through a reform on the social and health and welfare services in 
Finland’ (Finland Policy FI_2).  
Indeed, the previous government had considered a reform which would have involved 
earmarked taxes but it did not pursue this on the recommendation of the finance ministry 
(Finland Policy FI_2).  
Italy’s publicly funded health care system is financed through a number of earmarked taxes: 
a) an earmarked corporate tax (IRAP) on the value added of companies and public sector 
salaries, b) a regional surcharge on the national income tax (addizionale IRPEF) of up to 
0.5% on either a flat rate or adjusted for income brackets, and c) a fixed proportion (currently 
38.5%) of national VAT revenue used for the national equalisation fund, to supplement 
funding in poorer regions unable to fund the core health benefit package.42 IRAP and IRPEF 
rate levels can be further increased by regions facing budget deficits, and with an unevenly 
distributed tax base, poorer regions tend to take advantage of this mechanism most. 
Under another scheme also implemented in Italy, following legislation at the end of 2015, 
employers who agree to provide LTC services to workers and their relatives are able to claim 
income tax exemptions and the same applies to employees. The maximum amount for relief 
is up to €2,000, as long as income does not exceed €50,000.43 The idea is that companies 
would share their performance-related bonus in the form of services or vouchers for services 
instead of increased salary. On the one hand, the state would have less revenue from 
corporate taxation; on the other hand, there would be less need for public service provision 
as this would be done through private channels. The reform has been welcomed by society, 
but there are concerns about inequity, since large corporations and trade unions can 
negotiate better agreements than small firms and employees who are not part of large trade 
unions:  
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‘These amounts of resources set free by the state… allow enterprises to use a huge amount 
of bonuses, performance bonuses for something which goes between €8 and €9 billion per 
year to direct them towards LTC sector. The barriers probably might be there, especially for 
smaller companies who do not have so much resources to implement it or put in place these 
kinds of schemes unless they join other networks’ (Italy Academic IT_1). 
A novel approach to hypothecation of a small part of income tax is also in operation in Italy. 
Individuals can choose to allocate 0.5% of their income tax payments to any of a list of non-
profit organisations, including (but not limited to) those delivering or supporting health care 
and social care. The figures available indicate that payments allocated to health care 
organisations from this tax totalled just over €14 million in 2013.44 The figures available 
indicate a dramatic fluctuation in the payments allocated to health care organisations from 
this tax, dropping from just over €51.5 million in 2012 to just over €14 million in 2013.* 
Reliance on such an unpredictable source of revenue for health or social care funding would 
make balancing the budget difficult; in any case, this system provides only a very small 
amount of revenue for eligible institutions in Italy.  
In France, employee payroll contributions to mandatory health insurance have been slowly 
replaced since 1988 by a hypothecated tax called the ‘general social contribution’ 
(contribution sociale généralisée; CSG). The CSG is based on total income rather than on 
only earned income and was adopted as part of attempts to broaden the SHI system’s 
revenue base. The rate varies depending on income source and level of earned income, and 
applies at a rate of 3.8% of earned income for almost half of French households on low 
incomes who were otherwise exempt from income taxation. In this case, it appears that it is 
the change in revenue source (from a broader revenue base and partially disconnected from 
earnings) that has been key to this reform, rather than its status as a hypothecated tax.11 
Pre-funding 
Most governments of high-income countries recognise that baby boomers’ (people born in 
the decade or so following the end of the Second World War) retirement and future needs for 
health care and LTC are likely to pose a challenge. This casts a particular light on the 
hypothecation debate as well as raising issues of intergenerational equity: to what extent 
should a cohort of the population be expected to pay for their future care by contributing to 
funds that are put aside now, to be drawn upon in the longer term, when care needs to be 
paid for? What guarantee would they have that the funds will not be raided before that time 
by governments perceiving more pressing needs? 
The German federal government has started a fund that receives 0.1% of the income 
collected from public LTCI contributions (currently set at 2.55% of income in total, or 2.80% 
for people without children); the money being collected will be set aside and not used until 
                                                
* The trends over two years also indicate dramatic fluctuation in the payments allocated under this scheme, 
dropping from just over €51.5 million in 2012 and to just over €14 million in 2013.44 
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2034, by which time it is expected that baby boomers will be putting greatly increased 
pressure on the LTC system. As one German academic noted:  
‘[2034] is the year when the baby boomers in Germany are at risk of getting long-term care. 
So we have this payment to accumulate money for this group that are at risk of getting long-
term care in about 2035’ (Germany Academic DE_3). 
In a comparable initiative in 2001, but not aimed at long-term care per se, the New Zealand 
government established and started paying into the New Zealand Superannuation Fund 
(commonly known as the Cullen Fund after the then minister of finance 
https://www.nzsuperfund.co.nz/). This was done to take advantage of a strong economy at 
the time, in order to partially pre-fund the state pension scheme, the cost of which is 
expected to greatly increase in the longer term as a result of New Zealand's ageing 
population. Payments into the fund were suspended in 2009 in the face of rising public debt 
as a percentage of GDP and have not yet resumed. 
‘Sin taxes’ 
A special form of earmarking is the use of taxes on health-damaging products such as 
tobacco, alcohol, sugar or fats (‘sin’ taxes) in order to finance health care; this has been 
discussed in the context of the WHO Framework Convention for Tobacco Control. Another 
variant might be financially penalising those, such as drunk drivers, whose anti-social 
behaviour leads to health care costs. Sin taxes may appear attractive to some policymakers 
as they simultaneously raise some revenues and discourage unhealthy behaviours. We 
found that while all reviewed countries, including the UK, levy taxes on tobacco and alcohol, 
and the UK has introduced a tax on sugar-sweetened soft drinks, the revenues raised by 
them are typically not earmarked for spending only on health care. One possible exception is 
France where revenues from tobacco taxes contribute to the CMU fund, which provides 
health care coverage for people on low incomes. For example, the 2013 Social Security 
Finance Act added 3.15% of revenues from tobacco taxes to the CMU Fund.11 However, 
attempts in the early 2000s to earmark revenues from taxes on alcohol were not successful:  
 ‘[W]e did make many attempts to do the same for alcohol but failed because of the strong 
lobbying in France. We made very little progress on alcohol tax. We looked at several taxes 
on harmful products. However, today, the room for manoeuvre is relatively small’ (France 
Policy FR_1). 
In most countries, taxes on health-damaging goods are being levied in an effort to target 
consumption patterns rather than to close (much larger) funding gaps. Several countries 
have been discussing levying taxes on sugar, eg Finland (Finland Policy FI_2) and Sweden 
(Sweden Policy SE_1), but in both cases these would be intended to reduce consumption 
and improve health behaviours rather than to generate revenues for health care. Similar 
experiences have been reported for Germany, where there is interest in introducing a tax on 
sugar or other unhealthy foods, but again only with the intention of improving health 
behaviours, not with the goal of financing mandatory health insurance:  
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‘Instead it’s with the goal of creating incentives for people to behave in a healthier way. But 
the additional income for the state would not go to statutory health insurance. Perhaps the 
outgoings might be indirectly reduced because people are healthier, but that’s difficult 
anyway’ (Germany Policy DE_5). 
Likewise, there have been discussions in New Zealand about the introduction of a sugar 
tax45 but this is also not seen as a means to raise revenue but to change behaviour. No 
decisions have been made so far:  
‘The government’s policy is that they’re going to wait for better evidence that it works. 
They’re looking… there’s a couple of major studies underway looking at the impact in 
Mexico. They’re also going to observe what happens in the UK and whether the levy on 
manufacturers does indeed lead to reformulation’ (New Zealand Policy NZ_1). 
For the Netherlands, one interview participant commented that while increasing taxes on 
certain unhealthy goods may be desirable from a health perspective, such a move would 
likely attract opposition from the finance ministry, which is ‘not in favour of more, different 
taxes’ (Netherlands Policy NL_5). 
Hypothecated tax and the NHS: debates and implications 
The persistent interest in political and policy circles in implementing a designated NHS tax 
for the UK has been noted by a number of authors.32,36,46 Existing examples of tax 
hypothecation in the UK include not only the television licence fee, as mentioned earlier, but 
also the soft hypothecation introduced by Gordon Brown in 2002 when National Insurance 
Contribution rates were increased with the explicit intention to spend the extra revenue on 
the NHS.32  
The National Insurance Fund (NIF) has been put forward as another prominent example of 
soft hypothecation, as it is notionally used to fund public benefits.37 Indeed, supporters of an 
NHS tax have proposed the full hypothecation of National Insurance (NI) contributions to 
fund the NHS.32 However, others have presented a number of reasons why this would be 
inappropriate.37,41 As NI applies to employers and employees under the state pension age 
only, such an approach would generate intergenerational disparities and any future changes 
in NI rates to keep up with demand for NHS care would disproportionately affect those 
relying on earned incomes rather than asset wealth or a pension.37,41  
The viability of a hypothecated tax may depend ultimately on how far members of the public 
trust the government to allocate funding in their best interests. As Doetinchem47 notes, ‘The 
same argument is made in favour of as well as against hypothecated taxes. While 
proponents argue that they limit a government’s propensity to spend according to their own 
agenda, critics retort that they curtail a government’s flexibility to spend when and where it is 
needed most.’ 
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4.3 Is mandatory (social) insurance the way to go? Case study: long-
term care insurance in Germany 
One of the ways to fund LTC is through a mandatory social insurance system. In essence, 
individuals are required to contribute to a fund throughout their adult lives and they are then 
entitled to LTC, should they need it in case of a disability or frailty. The economic principle is 
the same as in any insurance. The greater the number of people who contribute to the 
system, the more risk-pooling there is and the lower the contributions each person has to 
make to the fund in order to insure themselves against the risk of high costs being incurred 
in future.48 For (any country of) the UK to consider introducing mandatory insurance for long-
term (social) care, it is instructive to look at Germany, a country that implemented statutory 
LTC insurance (LTCI) around 20 years ago. This allows us to gain insight into what setting 
up a newly introduced mandatory insurance system entails, although we recognise that 
Germany had already established the institutional structure for operating a nationwide public 
insurance scheme for health care (Box 4), a precondition which is not yet present in the UK 
context.49 
 
Box 4: Mandatory health insurance schemes in high-income countries 
Mandatory insurance for health care has been long established in several of the countries in 
our review. In Germany, the mandatory nature of statutory health insurance (SHI) was 
extended in 2009 to include all residents (until 2008, SHI was mandatory up to a specified 
income threshold only). As a result, the proportion of public expenditure on health that 
originated from mandatory insurance increased from 69.5% in 2008 to 77% in 2009.9 
Switzerland made the purchase of basic health insurance cover mandatory for all residents 
in 1996 (about 80% of the population also hold private health insurance to cover additional 
services)50. In the Netherlands, following the introduction of a single insurance scheme 
under the 2006 Health Insurance Act, all residents are required to take out nationally 
regulated, private health insurance. Residents contribute through a flat-rate premium, paid 
directly to the health insurer of their choice, and an additional income-related contribution is 
deducted through payroll and transferred to a central Health Insurance Fund.13  
In traditional SHI systems such as France, Germany and the Netherlands, contribution rates 
are typically shared between employers and employees, but the precise mechanism by 
which contributions are levied differs, and this has also changed over time in an effort to 
broaden the financial basis for SHI. For example, in Germany, the SHI contribution rate is 
determined from monthly gross salary, and this was historically equally shared between 
employers and employees. However, since the early 2000s, a series of reforms challenged 
this principle in order to stabilise the employer’s part of the contribution rate. This effectively 
involved an incremental shift of costs to individuals (see section 4.3). Conversely, France 
moved, in 1991, to payroll taxes (CSG) and from 1998, employees’ contributions have been 
based on total income. This replaced the previous system in which employees’ contributions 
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were based on earned income only (as in Germany) while employers’ contributions continue 
to be determined from gross salary (at 13% in 2013). In the Netherlands, calls to increase 
the income-dependent part of the mandatory health insurance premium have been resisted: 
‘That simply was not a politically acceptable way to go forward [at the time]’ (Netherlands 
Policy NL_5). 
 
 
How, when and why was the German statutory LTC insurance system created? 
LTC in Germany is funded through social insurance. But this was not always the case. In 
1995, Germany had a longstanding statutory health insurance (SHI) system in which every 
employer and employee made contributions to a fund that was used to cover the costs of 
healthcare and some LTC services. It was in that year, 1995, that the SGB XI (German 
Social Code, book 11) was implemented and guided LTCI funding in Germany. According to 
the law, anyone who had SHI was automatically covered by the statutory LTCI. Those who 
had private health insurance (PHI) were obliged to purchase private LTC insurance as well. 
The minimum period of contribution for eligibility was initially set at five years but was 
changed to two years in 2008. The change in 1995 happened after 20 years of discussions 
on how to reform the funding of social care.12,51 Until 1995, individuals were expected to rely 
on their own finances or family to pay for or provide long-term care. Those who had run out 
of capital and assets or were simply not able to provide for their own care had to request 
social benefits which were means-tested (Hilfe zur Pflege).52 The ever-increasing social care 
expenditures, especially after German reunification in 1990, began to create pressure to 
make changes to LTC funding.51  
How does the system work? 
The German statutory LTCI works as a ‘pay as you go’ system and contributions are split 
equally between employers and employees. The initial contribution rate was set at 1% of 
wages but there have since been several increases to address growth in the cost of care.51,52 
Table 3 shows the changes in contribution rates from 1995 to 2017. Since 2004, pensioners 
have also been required to pay at the same rate: thus, in 2017, the full rate of 2.55% is 
deducted from their pensions. Starting in January 2005, employed people over the age of 23 
who do not have children have been required to pay an additional 0.25% charge, so that 
childless adults currently pay 2.80% of their salary. The additional 0.25% charge is paid by 
the employee only, and not by the employer, who still pays at the rate of 2.55%.53 
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Table 3: Income contribution rates for statutory LTCI 
 
Rate 
Year Total Employee Employer 
Employee without 
children 
1995 1% 0.50% 0.50% 0.50% 
1996 1.70% 0.85% 0.85% 0.85% 
2008 1.95% 0.975% 0.975% 1.225% 
2014 2.05% 1.025% 1.025% 1.275% 
2015 2.35% 1.175% 1.175% 1.425% 
2017 2.55% 1.275% 1.275% 1.525% 
Source: German Federal Ministry of Labour and Social Affairs53 
This extra charge for employees without children shows that there is still reliance on care 
being provided informally by other family members. In fact, until the implementation of the 
LTCI system, individuals relied mostly on help from family, something so ingrained that there 
are legal obligations to care for an elderly member of the family.54 In view of this, the LTCI is 
not designed to pay for the entirety of LTC costs, but to cover basic services that enable 
individuals to carry on with their activities of daily living. 
For the general public, the LTCI system is straightforward and easy to follow. Automatic 
contributions are deducted from employees’ pay. Employees are automatically enrolled in 
the statutory LTCI, but those who are employed or self-employed and earning above 
€57,600 a year in 2017 can opt to take on private LTCI with the same benefits as the 
statutory LTCI. Civil servants, even those earning less than the threshold, must take up 
private LTCI.  
Eligibility and coverage 
The mandatory LTCI covers very nearly the whole population in Germany; only homeless 
and undocumented people are not part of it. In December 2016, 71.7 million people were 
insured by the statutory LTCI, and 9.4 million were insured through mandatory alternative 
private LTCI in December 2015.55 This near-universal coverage is a result of the generous 
criteria that allow individuals who have contributed for more than two years to also have their 
family members or non-earning dependents insured. The same applies for unemployed 
people whose LTCI charge is paid from their unemployment insurance (which in turn is 
funded from taxation).  
Individuals who have contributed for at least two years, and their dependents, are entitled to 
benefits based on a needs assessment test. Entitlement is independent of age, income or 
wealth. The needs assessment test ranks individuals in five categories, from low to high 
need, and benefits are provided accordingly. As a result of the Second Act to Strengthen 
Long-term Care, implemented in 2016, patients with dementia are also now included in the 
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LTCI system. Before this, individuals with dementia were able to apply for benefits but at 
reduced rates compared to other impaired individuals. As of July 2008, the amount was set 
at €100 per month (basic rate) to up to €200 per month (augmented rate). This amount was 
raised from the previous maximum €460 per year benefit, set in January 2002.53,56 
Benefits 
Insured people have a choice between benefits in cash, in-kind services or a combination of 
both. The value of benefits depends on the level of care needed, which is measured by a 
needs assessment test. The cash benefit is meant to facilitate and reward care-giving by 
relatives.57 When the benefit is taken in cash, the value is smaller than when taken in 
services. Most people still rely on family members for care, so LTCI beneficiaries may use 
cash benefits to compensate their relatives for their services. For example, the benefit rates 
for someone with Level 2 care need who opts to take cash rather than have services 
provided is €316 per month (Table 4). If, however, the person opts to receive up to six weeks 
of care in a calendar year as an in-kind service, payments are differentiated based on who is 
providing care – a family member or an independent third party. These benefits are not 
meant to cover the full cost of care, only a part of it. Even when benefits are provided in kind, 
some services are not included. Coverage of care in nursing homes, for example, does not 
include ‘hotel costs’, which need to be paid for by the insured person. People requiring social 
care still typically pay out of pocket for some of it and/or receive informal care from family 
members. About 4% of Germans have chosen to purchase additional private LTCI to 
supplement their mandatory public or private coverage.57 In Germany there is a legal 
responsibility to help pay for the care of near relatives. 
Table 4: LTC cash benefits in euros (as of January 2017) 
  
LTC monthly 
allowance €per month 
Benefits rate for up to 6 weeks of care in the 
calendar year (lump sum, in-kind service) 
By family members By other people 
Level 1 - - - 
Level 2 316 474 1,612 
Level 3 545 817.5 1,612 
Level 4 728 1,092 1,612 
Level 5 901 1,351.50 1,612 
Source: German Federal Ministry of Health.55 
 
Pre-funding LTC 
Germany experienced a baby boom between 1959 and 1967. As a result, in the 2030s there 
is very likely to be a bulge in the number of people who will become frail and need care. This 
was anticipated in the 2015 reform with the First Act to Strengthen Long-Term Care (Erstes 
Pflegestärkungsgesetz). In order to prepare in advance for this demographic change and the 
anticipated heavy burden on LTC expenses, the government has decided to set aside 0.1% 
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of contributions and place it in a fund that will not be used until 2035, when baby boomers 
are expected to need LTC, putting pressure on the system. It is estimated that this will raise 
€1.2 billion a year and help smooth and stabilise the contribution rate from 2035 onwards, 
which would have to be increased dramatically otherwise. 
The federal ministry of health describes this fund as being both necessary and efficient. The 
cohort born between 1959 and 1967 was larger than the previous and subsequent cohorts. 
Setting a pre-fund (Pflegevorsorgefonds) was deemed the best solution for the expected 
future pressure on the system. From 2035 onwards, up to one-twentieth of the capital 
accumulated will be used to provide LTC benefits over a period of at least 20 years. As the 
cohort that came after the baby boomers is smaller, the government felt no need to extend 
the fund. The reception from expert commentators has been positive, though with some 
qualification. In a 2014 article for the newspaper Süddeutsche Zeitung, German experts in 
health economics Wolfgang Greiner and David Bowles describe the pre-fund as necessary 
but too small to achieve its goal of smoothing contribution rates.  
The public reception has been good but there is some suspicion of how the fund will be 
used. The newspaper Die Welt reported that there was already pressure to access the fund 
early, the weekly magazine Der Spiegel has reported that the German Trade Union 
Confederation (DGB) is doubtful that the fund will be kept in place for the next 20 years,58 
and the Bundesbank has admitted that it cannot keep the fund out of reach of future finance 
ministers.  
Strengths and weaknesses 
LTCI can be seen as a form of hypothecation. One of the main advantages of having a 
funding system such as statutory LTCI is that the general public appears more willing to 
contribute financially when it is better informed about how the revenues raised are being 
spent. In other words, statutory LTCI helps to overcome distrust of government as it provides 
reassurance that the money paid will be used for a specific purpose and not siphoned off for 
something else.31 This is made clear by looking at the public acceptance of the system, 
including recent increases in contribution rates.57 The public perception, according to one of 
the experts we interviewed, is that the system is fair and necessary:  
‘… so the public is aware that we have a need of long-term care insurance and they are 
happy that we solve the problems with these mental health diseases, with dementia, etc’ 
(Germany Academic DE_3). 
Political acceptability is also enhanced since the general public support the system. When 
implementing reforms, people’s opinions paved the way: 
‘We have done some surveys and people agree that there’s a need for reform and 
depending on the survey it’s more than 50% agreeing to or being fine with increase of the 
contributions. So the same holds for the additional fee for childless people; the majority 
agree’ (Germany Policy DE_4). 
Having a contribution-based system also is thought by some to reduce the need for the 
political bargaining that is otherwise present in systems that rely on general taxation. In 
reality, however, the size of the LTCI contribution rates is also a result of political discussion 
and could go up or down just as budgets for LTC could rise and fall in a system funded by 
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general taxation. In practice, what we observe is that countries with statutory LTCI, like 
Germany or Japan, have either maintained or increased the size of their contribution rates 
while many countries that rely on general taxation have had budget cuts.* However, one of 
the potential downsides is that relying solely on a single source of funding may leave LTC 
budgets more vulnerable to macroeconomic fluctuations.59 If the labour market is weak, for 
example, revenue from payroll contributions will be reduced and this may lead to budget 
deficits that need to be addressed by using funds from previous surplus years, taking on 
debt or drawing funds from general taxation. If poorly administered, this system of LTCI may 
mean that expenditures will fluctuate with the peaks and troughs of the economy rather than 
smoothing them out, so as to continue to more closely match the trend in demand for care, 
which does not follow the macroeconomic cycle.  
Having an entitlement system could potentially lead to moral hazard. Individuals could 
possibly be less concerned about maintaining healthy habits and trying to minimise future 
reliance on care services, and might demand more extensive services when they do qualify 
for assistance. Evidence from France indicates a positive correlation between private LTCI 
purchases and alcohol consumption levels and body mass index.60 However, this does not 
necessarily mean that these individuals changed their behaviour only after insuring 
themselves. Indeed, it appears unlikely that people’s behaviour would be significantly 
influenced by future prospects around entitlement to social care. 
The German LTCI system and the UK 
The German and UK systems for funding LTC differ greatly from one another. While the 
German LTC funding system relies on mandatory insurance contributions, the UK system 
relies on general taxation. But if we compare today’s UK with the Germany of 1995, we see 
some similarities. With the exception of Scotland, the UK does not provide social care 
services free of charge. Individuals are expected to cover their care expenses out of their 
own pockets; only after they have spent their capital and assets and reached a low threshold 
value of remaining assets do they qualify for public funds through needs assessment tests. 
This was also true in Germany until 1995. Both the UK and Germany also have cost-sharing 
charges for most services, such as ‘hotel’ costs for care in nursing homes. Neither system, 
even in Germany today, is meant to fund the entirety of LTC cost. Both countries also rely on 
informal care from family members. Estimates from 2013 suggest that the value of the 
informal care provided in England alone ranges from £55 billion to £97 billion a year.5 
Implementing a German-style LTCI system in the UK would face some challenges and 
barriers. Most countries tend to make only incremental changes to their LTC funding 
systems, and those that have changed dramatically have only done so after years, even 
decades, of discussion. Were the option to be contemplated of introducing mandatory LTCI 
in the UK, this could not be done within a short timescale. Any system that replaces the 
current one would require a new administrative structure. Detailed consideration would need 
to be given to whether LTCI would replace, partly or wholly, income support payments that 
are currently available in the UK. 
                                                
* The International Long-Term Care Policy Network organised a conference in 2016. In a session entitled ‘Budget 
cuts and Long-Term Care Systems’, evidence was presented from countries such as the Netherlands, Poland, 
Italy, and the USA. 
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Replacing tax funding of LTC by a system of mandatory LTCI might be problematic for an 
individual devolved administration within the UK. Unless the same change were to be made 
simultaneously in all four countries of the UK, there would need to be a fundamental change 
to UK tax laws and arrangements to permit a devolved administration wishing to introduce 
mandatory LTCI to simultaneously reduce the burden of general taxation within that country 
by a compensating amount. 
Many people are uncertain about their own need for LTC or may prefer to rely mostly on 
family members, with no public assistance.61 This part of the population may be expected to 
resist having to pay for mandatory LTCI. Another possible barrier to LTCI is the belief by 
some that LTC should be provided free of charge by the state. This may be more likely in 
Scotland, where part of LTC is already being provided free of charge. 
4.4 Mandatory insurance does not take the politics out of funding. 
Case study: statutory health insurance in Germany 
The experience of mandatory health insurance in Germany illustrates that such a funding 
arrangement remains susceptible to repeated changes driven by government.  
One of the main challenges facing health systems that are largely funded from mandatory 
health insurance, and in which contributions are mainly based on earned income, is the 
dependence on a stable labour market in order to ensure financial sustainability. In 
Germany, the mandatory contribution rate for statutory health insurance (SHI) is determined 
from monthly gross salary, and this was historically equally shared between employers and 
employees. However, Germany has introduced a range of measures since the 2000s which 
involved shifting a greater part of SHI costs to individuals. This was an attempt to stabilise 
the employer part of the contribution rate, and so make labour costs more predictable, 
although this decision has been reversed more recently. We here trace the changes that 
were introduced in the German system over the past decade or so, describing the continued 
challenges faced by the system and the solutions that have been proposed. This highlights 
the role of the political context in enabling or hindering more fundamental reform – an issue 
not specific to Germany, of course, as we show in other parts of this report. 
The 2004 German health care reform 
Throughout the 2000s, political intervention in health care in Germany primarily sought to 
address financial deficits in the SHI system and to consolidate SHI financing overall.12 The 
deficits occurred in the context of broader economic stagnation in the early 2000s, with a 
continued rise in unemployment rates. In response, the then government launched the 
Agenda 2010 economic and social policy programme in 2003.62 The reform programme also 
targeted the health sector, with the 2004 SHI Modernisation Act (GMG) foreseeing a wide 
range of cost-containment measures (among other changes), including the following three 
key measures: 
• the exclusion of certain services from the SHI benefit catalogue such as 
reimbursement for non-prescription drugs and some types of patient transport  
• the redesign of out-of-pocket payments involving: (a) the introduction of co-payments 
for physician consultations in the ambulatory care sector (€10 quarterly practice fee), 
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(b) the move to cost-sharing for medical goods and services of 10% (a minimum of 
€5 and a maximum of €10 per good or service), and (c) the replacement of 
exemptions from co-payments for people under a certain income threshold by an 
annual limit of co-payments for every SHI member to 2% of annual gross household 
income (1% for those with chronic conditions)  
• the transferring of a greater part of the SHI contribution rate to the employee from 
July 2005, with 0.9% of the contribution rate to be solely paid by the employee, 
whereas the remainder was equally shared between employer and employee. 
Effectively this meant that the historical equal sharing of the contribution rate of 50% 
for both employers and employees shifted to 46% and 54% respectively. 
The need for more fundamental change: Bürgerpauschale versus 
Bürgerversicherung 
However, following these changes there was a consensus that the SHI system was in need 
of more fundamental reform, in particular as far as revenue streams were concerned.12 Two 
basic models were discussed by different (political) groups: a per capita premium or 
‘capitation fee’ (Bürgerpauschale), and citizens’ insurance (Bürgerversicherung). The former 
model essentially foresaw financing of SHI exclusively by SHI members via a community-
rated per capita premium (approx. €200 per month) independent of income (or age, sex, or 
pre-existing disease) for all adults (SHI members), while the existing employer contribution 
would be superseded and instead paid out as part of gross salary (and thus be subject to 
income taxes). People on low incomes would be covered via payments from general tax 
revenues. The private health insurance system would remain as it was. Conversely, the 
citizens’ insurance model would expand the existing SHI system by requiring all citizens to 
take out insurance; the upper wage threshold that entitles employees with higher salaries to 
opt out would be abolished (substitutive private health insurance would successively 
transition out) and the revenue base would be broadened in that other forms of income (not 
only wages) such as rental income would also be considered for determining contributions. 
A compromise: the 2007 health care reform 
Neither model succeeded. Instead, following the 2005 elections (and the formation of a 
‘grand’ coalition of Christian Democrats and Social Democrats), a compromise was agreed 
as part of the 2007 reform (GKV-WSG), which required all residents to take out health 
insurance (while retaining the principal separation of SHI and private health insurance) from 
2009. The special contribution rate of 0.9% paid solely by employees was retained. In 
addition, the government introduced the possibility for SHI funds to collect an additional 
community-rated premium or bonus (or a percentage rate) to compensate for financial 
shortfalls. This additional premium (‘capitation fee’) was to be paid solely by employees, 
although between 2009 and 2011, supplementary contributions could not exceed the lower 
of €8 per month or 1% of gross salary. This option was meant to stimulate further 
competition between SHI funds, the idea being that SHI funds would seek to reduce their 
costs so as to not have to impose an additional charge and risk losing members. In addition, 
SHI funds were able to offer a range of tariffs, enabling SHI members the option to pay a 
lower contribution rate or choose a tariff that entitled them to additional services and 
benefits. 
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The debate continues 
The 2007 reform was followed by another reform in 2011, under the subsequent 
conservative-liberal coalition government, which revisited the previous discussions about the 
move towards a ‘Kopfpauschale’ mainly as a means to separate health care costs from 
labour costs while further strengthening private health insurance.12 However, while the 2011 
SHI Financing Act did introduce further changes to the revenue generation aspects of the 
SHI system, the move towards a community-rated per capita premium was not pursued (it 
was widely perceived as ‘unsocial’ by large parts of the population). Key changes introduced 
by the 2011 reform concerned: (i) the uniform contribution rate, which from 2011 was to be 
set by law at 15.5% of gross salary (employees: 8.2%; employers: 7.3%); (ii) the 
supplementary contribution rate or premium, which was to become an income-independent, 
per capita premium and which was to be set by individual SHI funds (and so further 
strengthen competition between funds), while the upper limit of 1% of gross income was 
abolished; and (iii) the introduction of a so-called ‘social adjustment’ (Sozialausgleich) to 
protect those on lower incomes from the potential impacts of the supplementary premium, to 
be financed from the federal budget (the Bundeszuschuss). 
‘Ultimately, you have to say, the whole model failed, so this capitation fee was not received 
well at all by the population. It turned out that this social balancing payment via taxes is so 
complicated, because we don’t have a tax system, but we finance the health insurance 
through social security contribution, that basically, [the capitation fee] was dropped’ 
(Germany Policy DE_1). 
All of this was eventually changed again under the coalition government that came into 
power in 2013, with the subsequent 2015 reform seeking, among other things, to further 
develop the financing of SHI (GKV-FQWG). Among the key changes was the reintroduction 
of the parity of employee and employer contributions to SHI (parity had been abolished in 
2004). This means that from January 2015, the legally set contribution rate of 14.6% is 
equally shared between employers and employees. As before, the employer contribution 
remains fixed at 7.3% to ensure that the costs of labour remain stable. The special 
contribution of 0.9% to be paid solely by employees was abolished. However, the 
supplementary premium that can be imposed by individual SHI funds remained, although the 
previous community-rated premium was replaced by an income-dependent percentage rate. 
Again, as before, this additional premium is to be set at the discretion of individual funds to 
compensate for financial shortfalls. In 2015, the average premium was 0.9%. 
‘The abolition of this small flat rate [in 2015] and return to income dependent additional 
contributions, this also had a divided response in the media. The media that was convinced 
by the new concept criticised it, including the economic associations and also economic 
research institutes. They were very critical because it was viewed in regulatory terms as 
problematic. The competition was reduced between the insurers as the efforts towards more 
efficient care and tax financing for social compensation were considered as more sensible 
politically’ (Germany Academic DE_3).  
This is reflected in the latest annual report by the German Council of Economic Experts 
(2016/17), which reiterated its recommendation from its 2012 report to finance the SHI 
system through a per capita premium independent of income (Bürgerpauschale), with an 
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integrated social adjustment scheme, in an effort to decouple health care costs from labour 
costs and so keep the latter less vulnerable to fluctuations in contributions.63 
Tax funds to supplement SHI are growing over time 
While health care in Germany has traditionally been funded largely through mandatory 
insurance schemes, tax revenues also play a role. Tax funds were initially used to help cover 
care for residents who do not actively contribute to the SHI system; to cover non-personal 
health spending, such as prevention activities, health research, or training of health care 
professionals; or to maintain resource stability in the context of labour market fluctuations. 
But the role of tax revenue in the SHI system changed from 2004. Until 2003, SHI 
contributions were the sole revenue stream for publicly funded health care, but the 2004 
reforms included the introduction of a tax-funded federal contribution or subsidy 
(‘Bundeszuschuss’) to help cover care for dependents of insured members, or services for 
new and expectant mothers, for example. Starting from a low base of €1bn in 2004, the 
federal subsidy remained small until 2009 when, following the global financial crisis and as 
part of a wider macroeconomic package, the subsidy was increased to €7.2bn. This was 
later followed by additional increases during 2010 and 2011 to over €15.7bn to help prevent 
increases in SHI contribution rates and relieve the labour market of additional costs 
(Germany Policy DE_7). It has now been set at a planned €14.5bn from 2017 onwards.64 
While the added revenue from taxation is generally seen to be welcome in SHI systems and 
can be important for maintaining predictability of revenues in the face of labour market 
fluctuations, some commentators have been more cautious about the potential for 
unintended consequences. For example, key informants in Germany reported that with the 
introduction of tax revenue into the SHI system there is a risk that the federal ministry of 
finance might gain greater influence on decisions concerning the allocation of public funds. It 
was noted that the cutbacks in the federal subsidy in 2013-15 were ‘justified [by the 
government] by saying that the statutory health insurance funds were doing quite well 
financially. That is why tax funding can be temporarily cut… Every little reform by the 
ministry of health led to conflict with the ministry of finance and had to be negotiated’ 
(Germany Policy DE_5).  
Overall, the lack of predictability of the size of the funding that would be coming from the 
federal budget was also seen as problematic: 
‘The federal [budget]… often fluctuates a lot, i.e. is not stable, which means the insurance 
funds can basically not rely on it, because if the budgets are not well positioned in other 
places, then the [federal government] likes to help themselves out of that pot’ (Germany 
Policy DE_1). 
Relevance to the UK 
While the SHI system implemented in Germany may appear to have little direct relevance to 
the UK, given the reliance of the NHS on tax-based revenues, it serves to illustrate the 
continued struggle in other high-income countries to design a funding mechanism that is 
both economically sustainable and provides for a comprehensive package of services. The 
continued discussion about the need for more fundamental change, with the citizens’ 
insurance (Bürgerversicherung) among the themes debated in the negotiations leading to 
the formation of a new German government following the 2017 general elections, highlights 
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the challenges of breaking from tradition, although it is interesting to note that the proposed 
models of funding retain the core commitment to an insurance-based system. 
4.5 Voluntary insurance has a widespread role, but a minor one 
Moving beyond public revenue generation, voluntary health insurance (VHI) currently plays a 
fairly minor role in the majority of the countries included in the review, as it does in the UK. 
Even in the USA, VHI has essentially converted into mandatory insurance as a result of the 
Affordable Care Act. However, there are instances where VHI can play an important role in 
aiding the financial sustainability of the public system. Voluntary LTCI plays a minor role in a 
few countries but is generally less significant than voluntary insurance for health care. 
In Finland, voluntary private insurance has historically played a relatively greater – though 
still very marginal – role in health care financing than in the UK and some other countries: 
‘We do have a pretty lively private sector in health and social care, and also increased… 
private health insurances for different reasons… the public sector is giving a service promise 
which is satisfying certain needs, but then there are some additional insurance needs, and 
convenience needs, where private sector and private insurers do play a role’ (Finland Policy 
FI_2). 
There is an expectation that the forthcoming health and social welfare reforms discussed in 
section 4.1 may serve to draw some more formal distinctions regarding the publicly covered 
benefits and leave some space for private financing of services in the future (Finland Policy 
FI_2). This is seen to be of particular relevance in the future if demand for care outpaces 
publicly available resources. 
We highlighted earlier that in Germany, following the reform that made health insurance 
mandatory from 2009, there was an apparent decline in VHI as a share of total health care 
expenditure, but that this reflects a change in data reporting rather than an actual change in 
the proportion of the population taking out substitutive private health insurance instead of 
SHI. Indeed, the proportion of the population insured privately has remained relatively stable 
at around 11%. Substitutive private health insurance is open to those whose gross wages 
exceed a specified threshold, as well as civil servants and the self-employed.12  
A key challenge in Germany remains that private health insurance is seen as undermining 
the principle of solidarity governing the social insurance system. There is no financial 
equalisation mechanism between SHI and private health insurance that would take account 
of the typically higher incomes (and lower risks) of those opting to join private health 
insurance,12 which can be seen to pose a threat to the financial sustainability of the SHI 
system. Also, people with private health insurance tend to receive preferential treatment 
(shorter waiting times, more extensive diagnostic workup etc.). Hence, the reform introduced 
a higher income threshold for those eligible to switch from SHI to private health insurance.  
In Sweden there has been some debate about allowing voluntary insurers to play a larger 
role in health care financing, but it does not appear likely there will be major changes in the 
near future (Sweden Policy SE_1). Similarly, commentators from the Netherlands and New 
Zealand did not believe that VHI would assume a significant role in those countries in the 
near future (Netherlands Policy NL_5; New Zealand Policy NZ_1). 
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Box 5 provides a rare example in the EU of how VHI provided an important lever in ensuring 
the financial stability of health care financing during macroeconomic constraints. 
 
Box 5: Voluntary health insurance in Slovenia 
Voluntary health insurance was introduced in Slovenia in 1993 to cover co-payments for 
services otherwise paid for by the mandatory health insurance system. There are currently 
three providers of VHI. Unlike many other European countries, nearly all Slovenians 
purchase VHI coverage. This probably reflects the comparatively high level of co-payments 
for publicly funded health services. VHI premiums are lifetime-community rated and 
therefore affordable for most households. 
The 2008 global financial crisis led to a number of austerity measures, throughout which the 
public insurer, the Health Insurance Institute of Slovenia, was able to remain solvent in part 
by raising co-payment rates. This shifted costs from the public purse to VHI but without 
causing severe financial hardship for users of health care, as it meant that households did 
not have to pay out-of-pocket for care. 
Subsequently, successive governments in Slovenia have tried to dismantle the VHI market, 
perceiving it to be wasteful and generating profits that are not used for health care. Under 
the current government, there is a proposal to replace VHI with a levy and remove all co-
payments. This proposal has gained widespread political support, although it remains to be 
seen whether it will be successful. It has been estimated that the levy would need to 
generate around €400 million per year to fully substitute for the revenues generated through 
VHI. 
Sources: Cylus65 and Thomas et al.66 
  
Various voluntary LTCI arrangements have been advocated in a number of countries but 
only two have a significant voluntary private insurance system for LTCI: the USA and 
France. In the USA, around 10 million people have LTCI, which is approximately 3% of the 
total population.67 In the USA, the Community Living Assistance Services and Support 
(CLASS) Act was passed as part of the 2010 ACA package, but was not implemented and 
was repealed in January 2013.68 There was growing unease about the possibility of low and 
selective uptake in these schemes, which would undermine the key benefit of risk-pooling. 
These expectations probably stem from the experience of private, voluntary LTCI 
internationally, which, with the possible (but special) exception of the French case, has 
shown very modest uptake in the population. Even in the USA, where the use of voluntary 
private health insurance is widespread, rates of voluntary private LTCI are below 10% of the 
population over the age of 40.  
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In France, 7.3 million people were privately insured against LTC needs in 2014, or 11% of 
the total population.69 A combination of factors has led to this relative, though still modest, 
success of the French private LTCI market.70 First, the public benefit available, the APA, is 
modest and covers less than a third of LTC cost, which encourages people to look for LTCI 
to supplement public coverage. Second, the small premiums paid, thanks to employer-based 
products, are encouraging to take-up. The average annual premium for these contracts, 
which makes up 75% of all contracts, was €70 in 2015. Third, ‘family responsibility’ laws 
holding adult children responsible for care costs incurred by their parents are still in place 
and private LTCI is purchased in order to protect family members from the need to pay for 
or/and provide care. 
4.6 User charges. Case study: evidence on the impact of health care 
user charges   
No discussion of options for funding health care and social care would be complete without 
consideration of user charges, regardless of how unpopular they may be. If public funding is 
insufficient to meet all needs, countries may choose to institute or raise user charges in an 
effort to raise revenues and reduce excess demand. Hitherto that reality has evidently been 
much more accepted (in high-income countries) for social care than for health care. User 
charges are a generally small but highly controversial part of total funding for health care, 
and a larger but rather less controversial part of total funding for social care (Appendix E 
provides details on cost-sharing arrangements for health care and also for social care in the 
countries reviewed). 
In the following paragraphs we focus on the more controversial area of charges for people 
accessing health care. We first clarify the rationale for user charges and the various main 
types. We then describe the extent of user charges for health care, also known as cost-
sharing, in the countries we reviewed, and how such charges are becoming part of policy 
debates about future funding.  We conclude by summarising the evidence about the impact 
of those charges, and hence their relevance in a UK context. 
Rationale for user charges 
In most high-income countries, there appears to be a widespread conviction that health care 
is not a commodity like other commodities, because health care expenditures are largely 
imposed on individuals, rather than freely chosen. It follows that the financial burden should 
not disproportionately rest on those who suffer from illness, i.e. that it should be largely 
independent of the health risks. User charges, i.e. prices paid at the point of service, by 
definition go against this basic ethical intuition (Schokkaert and Van de Voorde, p.33971).  
Nevertheless, nearly all health care systems in such countries, including the NHS in the UK, 
make some use of charges to patients at the point at which they receive care. 
Charges for health care at the point of service have two main purposes. The first is to 
counteract the tendency for care services, if free of charge to the user, to be demanded even 
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if the value they bring the patient is less than the cost to society as a whole of supplying the 
services. In public debate this may be phrased as introducing (or increasing) charges so as 
to deter ‘unnecessary’ or ‘frivolous’ use of costly health services. By charging a price, it is 
hoped to deter frivolous use. But it may also put off some patients, especially those with low 
incomes, from seeking necessary health care. 
The second purpose of user charges is to raise revenues to contribute to funding the health 
service. In most health care systems in high-income countries, user charges currently 
contribute only a small percentage of the total funds required by health services. In the NHS 
in England, the two main areas of user charges for health care are prescription charges and 
dental charges, which raised £555 million and £777 million respectively in financial year 
2016/17, representing together just 1% of the total gross NHS costs in England of £139 
billion in that same year.72 Dental charges are levied throughout the UK, but prescription 
charges have been removed in Northern Ireland, Scotland and Wales. In other high-income 
countries, patient charges may sometimes be more significant than in the UK, but they are 
still a small part of the total funds required: in Germany, patient charges totalled more than 
€40 billion in 2011, but that was only 13.7% of total health service expenditure there.12 
The main constraint limiting the application of user charges has been the likely unequal 
impact they would have on different socioeconomic groups. As reflected in the earlier quote 
from Schokkaert and Van de Voorde, health care is, to a large degree, not a matter of 
individual choice; the need for it is largely unpredictable – hence the need for insurance of 
some kind – and to expect people to pay extensive charges at the point they receive care 
would be to exacerbate their misfortune in requiring that health care in the first place. 
Furthermore, user charges for health care are ‘regressive’. That is, on average, the lower a 
household’s income, the greater the proportion of it that would be spent on health care 
charges were they to be levied. The desire not to penalise people financially for being ill and 
not to burden low income groups proportionally more than high income groups form the 
basis of arguments against health care user charges. 
A ‘work around’ is to introduce systems of exemptions or caps on expenditure per time 
period – eg for the chronically ill, children, the elderly, those on low incomes – alongside the 
imposition of user charges. Indeed, when health care user charges are imposed, there is 
usually a list of exemptions from those charges, too. While reducing negative impacts on 
social equity, exemptions and expenditure caps simultaneously undermine the rationale for 
imposing charges: the deterrent to unnecessary demand for services is removed from those 
who are exempt from charges or have reached the expenditure cap, and the revenues 
raised by charges are reduced. The latter is particularly evident in the exemptions from 
prescription charges in the UK: these exempt approximately 50% of the population from 
paying charges but as they are precisely those people who have the highest demand for 
prescribed medicines the consequence is that more than 90% of prescriptions dispensed in 
England are exempted from the prescription charge. 
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A secondary disadvantage of user charges is the cost of administering them. The charges 
have to be collected and the exemptions and expenditure caps have to be policed. This 
entails administration costs, which may not be high but which nonetheless offset the 
revenues raised from charges, which are themselves quite modest. 
Types of health care user charges 
In this paper we define user charges broadly, to mean any payment required of patients at 
the point at which they receive care. For the purposes of our discussion we are excluding 
those services where the patient is required to pay 100% of the cost, because that service 
has de facto been removed from the basket of health care services. Our focus is on raising 
revenues to fund the existing basket of services made available by the NHS (and social 
care) in the UK, not on reducing the range of services offered. 
The main forms of user charges in health care are as follows: 
• fixed fee/copayment – the user pays £X every time they use service Y 
• percentage co-insurance – the user pays X% of the cost of the service. That cost is 
usually published in a tariff of prices applied to all providers, but in some cases it may be 
left to the service provider to determine the price, which could then vary from provider to 
provider 
• deductible – the patient must pay for the first £X of health care that they use in a 
specified time period (commonly a year, but it could be a quarter or a month or any 
other time period). Once their cumulative health care expenditure in that period exceeds 
£X, all subsequent health care within the specified time period is then either provided 
free of charge, or is charged to the patient at less than 100%, via a copayment 
arrangement or limited fixed fees or both. 
• balance billing – also known as ‘extra billing’ or ‘supplementary billing’. In some health 
care systems, providers are permitted to set their own charges, but the system payer 
(insurer or tax-funded health service) will only pay up to £X for those services. If patients 
want to obtain their care from providers charging more than £X for the service, then the 
patient must pay the balance. 
All of these forms of user charges are in use somewhere. Hybrid approaches combining two 
or more of these types of charges are also possible and in use. Table 5 and Appendix E 
show the charging approaches used in the UK and some other high-income countries. In 
practice, all forms of charging are commonly combined with exemptions for some population 
groups on grounds of their high health care needs or their low incomes. Caps on the 
maximum anyone is expected to spend on health care and fund out of their own resources 
per time period are also common, as charges could accumulate over time to become large 
burdens for some people. Table 5 and Appendix E show the kinds of health care services 
that are charged for in practice. In summary, all categories of health care services are the 
subject of user charges somewhere among high-income countries. 
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Table 5: Types of user charges in use in selected high-income countries* 
Type of charge Primary care/ GP 
services 
Prescribed 
medicines outside 
hospital 
Specialists 
outside hospital/ 
specialist 
outpatients 
Inpatient care Dental care** 
Fixed 
fee/copayment 
Finland, Sweden Australia, England, 
Italy (some regions) 
Finland, France, 
Italy, Sweden 
Finland, Germany, 
Sweden  
England, Finland, 
Northern Ireland, 
Scotland, Wales 
% co-insurance Japan, Korea, New 
Zealand 
Finland, France, 
Italy (some 
(regions), Japan, 
Korea 
Japan, Korea Japan, Korea Germany, Japan, 
Korea 
% co-insurance + 
fixed fee 
France   France  
Deductible  Netherlands Netherlands Netherlands  
Deductible + % co-
insurance 
Switzerland, US 
Medicare*** 
Sweden, 
Switzerland 
Switzerland, US 
Medicare*** 
US Medicare*** Sweden 
Deductible + % co-
insurance + fixed 
fee 
   Switzerland  
Balance billing Australia     
% co-insurance + 
balance billing 
 Germany Australia   
Notes: 
* Payment arrangements can be intricate; this table is a simplification. Note also that in most countries user 
charges are applied in conjunction with caps and/or exemptions. 
** In many countries other than those listed in this column, patients must pay 100% of dental charges. In those 
countries dentistry is thus excluded from the basket of services offered by the public health care system. 
*** In this table, for the USA we refer only to the publicly funded Medicare system. Within the large US private 
health insurance system, most types of payment are in evidence somewhere. 
 
Reforms and initiatives to change role of cost-sharing 
All reviewed countries impose some degree of cost-sharing for health care services covered 
under the statutory system. Table 5 and Appendix E provide an overview of the range of 
cost-sharing arrangements in a range of OECD countries. There is a clear contrast in the UK 
between health care, which has remained mostly free of charge at the point of use, and 
social care, which many people have to pay for at the point of use. 
As Table 6 shows, at least some patients are charged something for prescription medicines 
in almost all of the countries in our review. In England, but not the other countries of the UK, 
a fixed charge is paid by the patient each time a prescription is dispensed outside hospital, 
although that is only the case for approximately half of the population. People aged over 60, 
pregnant women and new mothers, children under 16, those with certain medical conditions 
such as cancer, epilepsy and diabetes, and people on a low income are all exempt from 
prescription charges. In all countries of the UK, patients pay a significant proportion of the 
costs of NHS (non-hospital) dental care and optical care. Proposals to introduce charges for 
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other parts of NHS care, such as for seeing a GP, are a recurring feature of the health care 
funding debate in the UK.*  
Internationally, user charges for medicines most often take the form of co-insurance (with 
differentiated rates) or fixed prescription charges. Several countries also use deductibles. 
The level of cost-sharing required varies among countries, although each system applies 
uniform rules, with most countries offering some form of mechanism to protect the income of 
selected population groups, for example through reduced rates (eg concessional 
beneficiaries in Australia), exemptions from charges (eg children and pregnant women in 
England, Italy, Sweden; pensioners and people on low incomes in Italy and England; some 
people with chronic conditions and disabilities in England, France and Italy), annual caps on 
expenditure (eg Australia, Sweden) and complementary private health insurance covering 
statutory user charges (eg France). Medicines dispensed in the inpatient hospital sector do 
not typically incur a separate co-payment. 
 
                                                
* See for example: http://www.pulsetoday.co.uk/news/practice-news/half-of-gps-in-favour-of-charging-for-routine-
appointments/20003741.article and  http://www.bbc.com/news/health-38913394 
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Table 6: Cost-sharing arrangements for prescription medicines in 14 countries 
 User charge 
required 
Exemptions Maximum out-of-pocket limit 
Chronically 
ill/disabled 
Low income Age 
Australia Yes Yes Yes Older people, 
children 
After reaching annual cap of AUD 1,475.70 
(2016) low-income earner cost per prescription 
(AUD 6.20) applies  
Annual cap of AUD372 (2016) for low-income 
earners (concession card holders) 
Canada Yes -  Yes -  Varies by plan 
Finland Yes Yes - -  Yes 
France Yes Yes Yes -  -  
Germany Yes Yes - Children 2% of annual net household income (1% of 
income for chronically ill) 
Italy Yes Yes Yes Older people, 
children 
-  
Japan Yes -  Yes Children 
(reductions) 
Monthly co-payment cap depending on age 
and income 
Korea Yes Yes Yes - Expense limit for all cost-sharing is based on 
the average health insurance fee per year 
Netherlands Yes -  - Children Annual deductible 
New 
Zealand 
Yes -  Yes Children -  
Sweden Yes Yes -  Children -  
Switzerland Yes -  -  Children Set at CHF700 for adults and CHF350 for 
children (treatment costs, incl. drugs) 
England 
(UK) 
Yes Yes Yes Older people, 
Children 
-  
USA Varies Varies Varies Varies Varies  
 
Where countries face concerns over generating adequate public revenues, it is conceivable 
that increases in cost-sharing may be seen to play a role. Cost-sharing may also be 
attractive for those interested in reducing demand for care. However, we find limited 
evidence that the countries included in the review are taking steps to draw increasingly on 
direct payments from households to finance their own health care. 
In Germany we find, on the contrary, that cost-sharing arrangements that have been 
implemented have ultimately been reversed. As part of the 2004 German health care reform, 
a quarterly fee of €10 was introduced for visits to physicians in the ambulatory care sector.12 
The fee was, however, abolished in 2013, mainly because this measure did not result in 
reduced utilisation rates as had been intended: 
‘So the practice fee, well, how do you say, it was well meant, but not well done… out of this 
solidarity thought, the ones who are sicker shouldn’t be in a worse position, so in that 
respect, it wasn’t received well, but this steering, guiding function of the GP could basically 
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not be implemented, i.e. the free choice of physician is a, how do you say it, a golden calf 
here in Germany’ (Germany Policy DE_1). 
In Germany, changes in co-payments are not expected, at least in the short- to medium-term 
future, mainly because the financial situation of the mandatory system is seen to be fairly 
stable for the time being, but also because of the experience with the practice fee: 
‘If at all, then it is currently being discussed how we can further reduce co-payments. We 
have the good financial situation where [mandatory] health insurance is used to consider 
how we can do more good for various parties. The discussion currently isn’t about how can 
we introduce co-payments again, how can we make it useful, but with the abolishment of the 
practice fee, it’s relatively avoided territory for health politicians. And basically we keep away 
from it at the moment because the financial pressure doesn’t exist, so we take a step back 
from it’ (Germany Policy DE_5). 
In New Zealand, co-payments in primary health care are a traditional feature of the system, 
with successive adjustments over the years involving health care subsidies for people on low 
to middle incomes. The co-payments also vary from primary care physician to primary care 
physician where they constitute the difference between government subsidies and physician 
fees.10 Following the 2001 Primary Care Strategy, funding for primary care was significantly 
increased, which helped reduce co-payments, but the government ‘could not afford to make 
it completely free’ (New Zealand Policy NZ_1). 
In the Netherlands a mandatory deductible is in place for all citizens aged 18 years or older, 
requiring individuals to cover health care costs in a given year up to the deductible amount 
out of pocket (except for GP consultations, maternity care and home nursing care).13 The 
level of the deductible has been rising since 2008, from an initial €150 to €385 in 2016. On 
an individual basis, some municipalities will pay the deductible for very poor households. 
However, in general most people have to pay and in 2013, about half of the insured 
population paid the full deductible.13 There are very few additional out-of-pocket payments 
for health care in the Netherlands (Netherlands Policy NL_5). The evidence of whether the 
deductible reduces utilisation of care services remains unclear, although there has been 
political debate about whether the deductible should be lowered or even abolished in the 
future. 
In Sweden there have been only limited debates on changing the maximum amount that an 
individual can be required to spend out-of-pocket on health care in a given year in a cost-
sharing context, and there has been no action thus far (Sweden Policy SE_3). Increasing 
user charges does not currently appear to be on the agenda, although it could be in the 
future (Sweden Policy SE_1). 
With respect to social care, nearly all provision of service in the countries included in our 
review requires some contribution from the care user, whether it is for home care or care in 
nursing homes, regardless of the basis for entitlement. In Japan there is a standard 10% 
(means-tested) co-payment for LTC with a recent 20% co-payment for wealthy users, and 
means-tested charges for care home accommodation and meals. In France, although 
access to the APA system is universal, as in the German and Japanese systems, the 
amount of support people receive is dependent on their financial means as well as their level 
of assessed need. Public funding coverage ranges from 90% to 10% of the assessed care 
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costs, depending on the service user’s income and assets. Recipients are expected to make 
up the remainder from their own resources. The French APA is an example of a ‘progressive 
universal’ system. As noted above, the German system also only covers a part of the costs 
of LTC, with the expectation that remaining costs are met out of pocket (potentially also with 
the help of means-tested social assistance benefits). 
The comprehensive systems of the Nordic countries generally have smaller co-payments. In 
Finland the co-payments are based on income (but are constrained so that they never 
exceed the actual cost of care). The exact percentage of income to be paid depends on the 
type of care. For residential care, the cost should never exceed 85% of the user’s monthly 
income and at least €90 should be left for the patient, per month, after fees are paid. For 
home care, fees depend on the number of people living in the patient’s household. For a 
person living alone, 35% of any income above €573 is paid towards fees. In Sweden, care is 
free of charge for individuals who earn less than SEK 4,679 a month, but above this limit 
there is a charge that can go up to SEK 1,772 (Swedish Government, 2015). These charges, 
however, account for only 4% of the overall funds for LTC. This share has been consistent 
over the years.18 
As regards the safety net systems (eg the UK and the US Medicaid system), access to the 
public social care system is means-tested, and those who are not eligible are expected to 
meet the full costs of care from their own means (albeit often with the support of some 
universal disability-related income support benefits, such as Attendance Allowance in the 
UK). A partial exemption exists in Scotland, where free personal care is available. However, 
in both cases the services that are free of charge are not comprehensive. For example, in 
Scotland accommodation costs in care homes and practical care are still subject to (not 
insignificant) means tests. 
Even for people who are eligible for some public support in means-tested safety net 
systems, charges are high. In England, eligible care home residents are required to 
contribute all of their income in charges, leaving them with a small personal allowance. In 
Australia, there are standard fees that must be paid by all users, although these are capped 
on an income basis. For example, the daily fees cap for home care for low-income users is 
34.8% of the maximum daily cap for high-income earners. Also, there is financial hardship 
assistance for people unable to afford even the basic fees. Until recently, to meet 
accommodation costs in care homes, individuals were required to pay an accommodation 
bond. This system has now been replaced by a tariff of accommodation charges. 
In addition to the relatively high cost-share proportions required from individuals in most 
social care systems, there are also some examples of further increases in, or plans to 
increase, these charges. In the Nordic countries, a user charge was only relatively recently 
introduced. In Japan, a discussion about whether to increase the co-payment rate from 10% 
to 20% started in 2013; and the increase was implemented in August 2015 for high-income 
earners. In England, many local authorities now charge up to the maximum allowable, 
whereas previously, many set charges below this rate. In Australia fees are adjusted 
annually but changes need not be in line with general consumer price inflation. As regards 
the maximum basic cap rate in residential care, rates consistently increased above inflation 
until 2014, after which increases followed inflation more closely, sometimes with a reduction 
of fees in real terms. 
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Evidence on the impact of user charges 
As discussed earlier, part of the rationale for user charges in health care, in addition to 
raising revenues, is to deter some (‘frivolous’) demand. The problem is that the deterrent 
effect of charges is likely to be stronger not only where the benefit that the patient expects 
from the health care is lower (i.e. where the care is less effective or the patient’s demand for 
it is more ‘frivolous’), but also for people with lower incomes independently of their need for 
health care. The empirical literature addresses both the average impact of charging on the 
quantity of health care used, and how that impact varies between different groups in the 
population according to their income and likelihood of illness. 
The principal measure of impact is the ‘price elasticity of demand’, which is the percentage 
by which the quantity of a service that is demanded changes when there is a 1% change in 
the charge for that service. Thus, if a 1% increase in the charge for prescription medicines 
were to be associated with a 0.2% fall in the quantity of prescription medicines demanded, 
then the price elasticity of demand would be said to equal -0.2. 
It is also possible that increasing the price to the patient of using one health care service but 
not another may cause the patient to substitute the latter service for the former. For 
example, if user charges were to be levied on consultations with GPs, but not on 
attendances at Accident and Emergency (A&E) departments of hospitals, then we might 
observe reduced GP visits but increased A&E visits. There exists only a small empirical 
literature estimating such substitution effects. 
If user charges do discourage some people on some occasions from presenting for 
(effective) health care, then detrimental effects on their health may be expected. This may 
have the further consequence that demand for health care increases in the longer term, 
because health problems have been exacerbated by inadequate (or no) care at an earlier 
stage. If user charges are imposed on preventive measures, eg flu vaccination, then they 
also risk a direct impact of higher future health care costs in consequence. 
The famous RAND health insurance experiment is the only randomised controlled trial of the 
impact of user charges on the use of health care services. It ran in the USA from November 
1974 to February 1977 and studied health service use by 5,809 individuals randomly 
assigned across 14 different health care plans with varying levels of copayment. The 
experiment found that higher charges lead to lower use of health care, with a price elasticity 
of demand in the range -0.1 to -0.2.73 Reductions in use of care services were found to be 
the same for both ‘effective’ and ‘ineffective’ medical services. In other words, effective 
health care was as likely as ineffective care to be deterred by higher user charges. 
Kiil and Houlberg74 undertook a systematic review of the empirical evidence from 1990-2011 
(inclusive) of the price elasticity of demand for health care services subject to user charges, 
finding 47 relevant papers from a variety of (high-income) countries. It is currently the most 
recently published review of evidence in this area. We have extended their review by 
searching the empirical economics literature (published in English) on the EconLit database 
from January 2012 to April 2017 (inclusive), which revealed a further 14 papers with relevant 
empirical results. Taking this published empirical evidence together, we find that: 
• the evidence is overwhelmingly that user charges do lead to a reduction in use of health 
care services. A small minority of studies finds no significant association between 
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increases in user charges and reduced health care use but the large majority finds a 
negative relationship. 
• this negative relationship, where quantified, indicates a price elasticity of demand 
commonly in the range -0.1 to -0.3, with a cluster of estimates around -0.2, as in the 
RAND experiment. Thus to increase user charges by 10%, say, would be to expect a 1-
3% reduction in the quantity of those services taken up by patients. 
• similar magnitudes of price elasticities are evident for all kinds of health services: GP 
consultations; prescribed medicines; specialist outpatient care; visits to hospital 
emergency departments (A&E); hospitalisations; rehabilitation; prevention; and health 
care in total. (The first two of these types of care are the most common focus of 
empirical studies).) 
• there is little apparent difference in the price elasticity of demand for health care across 
different population groups. Chandra et al.75 focus on low-income groups in one US 
state and find magnitudes of price elasticity still in the same -0.1 to -0.3 range. 
• Chandra et al.75 find that adults aged 19-64 on low incomes and with chronic illnesses 
(asthma, diabetes, high cholesterol) respond less to user charges than do people of the 
same age on low incomes who do not have chronic illnesses: there is a price elasticity 
of -0.06 for those with chronic illnesses, compared to -0.27 for those without, and 
compared with -0.16 for the total low-income population in that age range. 
• there is very little empirical evidence about the effect of increased user charges for one 
type of health care service on the demand for other types of health care service. Kiil and 
Houlberg in their review74 refer to six studies of the impact on other services of 
increased user charges for prescription medicines. They report that two of the six 
studies show that increased prescription charges are associated with increased demand 
for hospital services and one with increased demand for GP visits, but the other three 
studies show no association. Two of the more recent studies we reviewed considered 
such substitution effects: Li and Anis76 found that higher co-payments for medicines 
were associated with more doctor visits and hospitalisations; but Ziebarth77 found no 
impact on doctor visits. 
• few studies have attempted empirical estimates of the effects of increased user charges 
on health. Kiil and Houlberg74 report that two of the studies in their review find an 
association between increased charges for prescription medicines and worsened health 
(increased mortality) and one found no such association. Among the more recent 
studies we have reviewed, only Shigeoka78 estimated impacts of user charges on 
mortality and other health outcomes and they did not detect any such impacts. 
Evidence on the price elasticity of demand for social care services is considerably scarcer 
than for health care, and what there is mainly focuses on the US. Forder and Allan79 
reviewed the few studies available at that time. Nyman80 suggests that private nursing home 
patients are very responsive to price changes, with a price elasticity between -2.3 and -1.7, 
but this indicates patients’ ability and willingness to go to an alternative provider when one 
provider puts up its price unilaterally, rather than their willingness to go without care if all 
prices rise. Nyman’s results confirmed two previous studies that found similar results but 
failed to control for supply-side factors and other sources of bias. In the UK, Forder81 used 
an alternative approach by calculating price elasticity through the price mark-up above 
marginal costs. Forder’s estimates showed price elasticities ranged from -0.08 to -0.28, 
which is very similar to the price elasticity of demand for health care noted above. The 
difference between findings from the UK and the US may be explained by the differences in 
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the samples used, according to Forder. The British data focused mostly on publicly funded 
patients with mental health problems, while Nyman used data from private nursing homes 
whose patients had varied conditions, an approach similar to other American studies. 
Despite a relative lack of research on price elasticity for social care, the little evidence that 
exists suggests that individuals react negatively to price increases. However, the magnitude 
of this negative effect is still disputed.   
Relevance to the UK 
Since the founding of the NHS in 1948, user charges for NHS care have always been 
controversial. But they were introduced early in the life of the NHS: for dentistry and 
spectacles in 1951 and for prescriptions in 1952; and charges have been present in some 
form ever since. Since devolution, the devolved administrations of Scotland, Wales and 
Northern Ireland have removed prescription charges, but have retained dental charges. Thus 
health care user charges are not without precedent in the UK and, as noted earlier, they are 
a recurrent feature of policy discussions. 
It would be administratively possible for providers of NHS services to collect charges from 
service users: NHS dentists and community pharmacies already do, and many NHS 
providers already collect income from private (non-NHS) patients. There would be an 
administrative cost involved in billing patients, or charging them at point of care (eg in the 
GP’s practice) but it would be feasible to do. 
User charges account for only around 1% of NHS funding in England currently, and an even 
lower proportion in the other countries of the UK. The main barrier facing extension of user 
charges for NHS services beyond this small base is the strong and widespread public 
opposition to them. A May 2017 Ipsos-MORI poll across Great Britain for the Health 
Foundation found that 88% of those polled were in favour of the statement ‘The government 
should support a national health system that is tax funded, free at the point of use, and 
providing comprehensive care for all citizens’ (emphasis added) (poll results accessible at: 
http://www.health.org.uk/sites/health/files/Polling2017_web.pdf). Over the years there have 
been many such polls, all with very similar results on the question of user charges. 
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5. Aspects of the funding environment 
that drive or constrain reform 
 
 
 
 
Overall, countries have taken different approaches to health and social care financing; there 
is no commonly preferred solution to achieve sustainable revenues. 
For the countries included in the review, we find that the emphasis remains on relying on 
public sources to fund health care, as is currently the case in the UK, with concerns 
expressed in a small number of countries about an eventual need to rely more on private 
funds. Some countries are either considering, or have previously considered, allowing local 
regions to generate their own revenues for health care. This may be as part of consideration 
of wider reforms of local government financing rather than specifically to raise additional 
funding for health and/or social care. However, it is important to note that in all of these 
instances, an equalisation scheme is in place to pool and reallocate resources in an effort to 
ensure some degree of equity. 
Importantly, we find no single source of public revenues that countries are focusing on to 
alleviate sustainability concerns. ‘Sin’ taxes, despite anecdotal popularity, are not being 
widely used in the countries included in the review to (co-)finance health care. 
Earmarking/hypothecation of taxes is also not common overall and does not improve the 
sustainability of resources for health and social care.  
Our research to date has, however, highlighted the importance of three major aspects of the 
funding environment that can act to drive, or to constrain, changes to the ways in which 
health and/or social care are financed: 
• the state of the wider economy 
• concerns with long-term financial sustainability rather than just more funds in the short 
term 
• the dominant influence of social and economic context and political factors in shaping 
reforms. 
All of these aspects apply as much to the UK as to the countries in our review. We discuss 
each aspect in turn below. 
This section explores three key aspects of the health and social care funding 
environment that can drive or constrain reforms: 
• the state of the wider economy 
• concerns with long-term financial sustainability, rather than just more funds in 
the short term 
• the dominant role of context and politics 
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5.1 Changes in the wider economy drive reforms to funding of care 
In all countries, economic factors play an important role in determining approaches to health 
and social care financing. Indeed, one interviewee noted how, in the Netherlands, all 
decisions regarding public budgets and revenue generation are considered in the context of 
how they will affect household incomes and purchasing power. For example, if the health 
care allowance were to be increased, policymakers would consider lowering the sums 
distributed by other forms of income-compensating policies.  
The ability of health care and social care financing mechanisms to generate sufficient 
revenues cannot be thought of in isolation from the broader economy. In contribution-based 
systems, revenues are dependent on wider economic performance that affects the labour 
market. In Germany, for example, ensuring sustainable financing of the SHI system has 
been among the major aims of successive governments since 2000.12 This has to be seen in 
the wider context of economic stagnation in the early 2000s, with a continued rise in 
unemployment rates (to just over 11% in early 2005). This also affected the SHI system, 
given its dependence on contributions from the paid labour force (and pensions). In 
response, the then government initiated a major structural reform (‘Agenda 2010’) in 2003, 
targeting the labour market, social policies (including health) and the financial sector. Widely 
seen as a departure from the traditional German social policy model, the reform has been 
perceived by some to have been crucial for the economic turnaround of the country 
(Schwander and Manow, 2016).82 Unemployment decreased steadily while employment 
increased. This has significantly increased the number of people subject to mandatory health 
insurance contributions, and their number continues to rise. These trends are seen to have 
ultimately benefitted the financial basis of the SHI system: 
‘Over the last five, six, seven years… we’ve seen a consistent increase in [SHI] income from 
year to year of 3-4% volume, [which] is enormous compared to the last 30 years. And that’s 
of course because every year there’s been a very good increase in the number of employed 
– with employees it’s considerably over 1% each year and then there are pay increases as 
well, which are also considerably higher in the last few years than in the 2000s’ (Germany 
Policy DE_5). 
Together with other measures, including reforms within the mandatory health insurance 
system, these measures have been viewed as putting SHI financing on a firm footing. One 
interviewee commented: 
‘Health insurers have a financial buffer and the Health Fund has one too. Together it’s 
approximately 28 billion currently… Although it’s not a transition to large capital reserves, but 
of course it’s different to the political situation’ (Germany Policy DE_7). 
Conversely, a thriving economy may also be seen as obviating the need to reform. For 
example, for Sweden, it was argued that the changing demographics should trigger changes 
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in the way the system is financed in a sustainable way but this has not become an issue 
because the Swedish economy has been stable:  
‘I think that government can sleep with good conscience because we still have a good 
economy. I’ve seen that when I’ve been out in Europe, and having discussions about elderly 
care, then I hear from UK, from Finland, from the Netherlands, the discussion is always 
about how we are handling all the cutbacks in financing. They ask me, so what is Sweden 
doing? How are you handling the cutbacks? What cutbacks? We’re getting more money 
every year into the system. Even though we have a demographic situation this last ten 
years, we haven’t increased our number of plus-80s. We have had some six, eight, nine 
years that have been very favourable’ (Sweden Policy SE_1). 
5.2 Ensuring financial sustainability may be more pressing than 
raising additional funds in the short to medium term 
While it is difficult to generalise from the countries included in the review, it appears that 
concerns about the long-term sustainability of public finances overall play a greater role in 
financing decisions than does interest in raising additional revenues in the short to medium 
term for health and social care. This is an important distinction, as pressure to increase 
health and social care funding may be weaker in many other countries than in the UK. 
For example, for France it was noted that increasing attention is being paid to improving the 
allocation of resources within health care rather than increasing the level of revenues 
generated: 
‘To be frank, the increase of funding for healthcare insurance is not the number one priority 
in France … and you know that health spending/GDP is traditionally quite high in France 
compared to other countries. We are convinced that there is a room for manoeuvre to make 
savings while retaining a good health service to the population’ (France Policy FR_1). 
Similar concerns were raised by stakeholders from New Zealand. While there is political 
debate about whether the health system is adequately funded given observed health 
outcomes, in particular in the indigenous population, not everyone agrees that additional 
revenue would solve this problem: 
‘So, there is an argument about whether that needs to be addressed by additional funding or 
by better organisation of existing funding, depending on which side of the political spectrum 
you’re on. Because of course, as you know, none of these things can be solved by hard 
evidence’ (New Zealand Policy NZ_1). 
Of note, since 1989 the New Zealand treasury has been required, by law, to produce a 
report on the long-term fiscal position every four years to identify future challenges and 
options for addressing them.83 Population ageing and health care tend to be among the key 
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issues but the degree to which recommended options are being taken up by the government 
varies: 
‘It’s sometimes something that politicians disregard because they don’t commission it, it’s 
something that treasury is required to do in legislation, so it’s sometimes an area where the 
civil service and the policy butt against each other’ (New Zealand Policy NZ_1). 
Likewise, while sustainability as such was reportedly less of a concern in countries such as 
Sweden, where the economy is expected to do well at least in the short to medium term, the 
focus of discussions there is on ensuring that resources are used efficiently, rather than on 
how to better generate revenues: ‘The biggest discussion in Sweden right now is not on how 
you get money into the system but how we use it’ (Sweden Policy SE_1).  
Some evidence of interest in sustainability rather than raising additional revenues can also 
be seen by looking at counter-cyclical measures countries have put in place. For example, 
there is recognition that VHI in Slovenia allowed the Health Insurance Institute to maintain 
access to health care services following the 2008 economic crisis without shifting the burden 
disproportionately to users of health care or raising additional public revenues (see Box 5). 
While there are currently efforts to dismantle VHI in Slovenia and replace it with a levy, 
previous reform efforts in this regard have not been successful. The health care allowance in 
the Netherlands also serves to buoy revenues for health care by increasing the tax-funded 
component of the health care system when households become poorer and unable to make 
income-related contributions. Closing the so-called sustainability gap in Finland has been a 
key driver of the forthcoming health and social welfare reforms. Expectations for depressed 
economic growth have heightened concern in Finland about fiscal sustainability and the goal 
of the reform is therefore seen as ‘not to reduce the budget, but to keep the projected costs 
under reasonable control’ (Finland Policy FI_2). 
On a related note, the reforms in the Netherlands were designed to improve sustainability 
through increased competition between health insurers. The evidence on whether this has 
occurred is mixed, particularly as expenditures increased fairly rapidly in the first years of the 
reforms.13 However, more recently, expenditure growth has slowed, which has not been 
attributed to the market mechanisms but instead because ‘government made an agreement 
with all the interest groups that annual healthcare expenses will grow to 2.5%, then 1.5%, 
and currently 1% per year. And that has basically been the threshold, or benchmark, in 
negotiations’ (Netherlands Policy NL_5). 
Social care, in comparison with health care, is arguably seen as something necessary but 
nevertheless more expendable when there are to be cuts in public expenditures. Exceptions 
to this tendency appear to be the Scandinavian countries, which were not hit as hard by the 
2008 economic crisis as other European countries were. Elsewhere among the countries 
where we interviewed key informants, we heard of efforts to contain social care costs. In the 
Netherlands there were budget cuts in 2015, while caution about overspending led to a 
budget surplus in that fiscal year. As described earlier, the Netherlands also reformed its 
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LTC funding system to incentivise care at home to allow people to remain independent for 
longer before being admitted to nursing homes, as a form of cost containment, which is in 
step with many people’s preference to receive care in their own home. In Germany needs 
assessment levels have changed so that lower levels of need for care are now granted 
home modifications, which allows users to stay at home for longer. Austria has strengthened 
their 24-hour-care programme, which has similar implications, and Japan implemented 
similar changes earlier, in 2005.  
5.3 The role of context and political factors in shaping reforms 
cannot be overestimated 
Country context, path dependency and societal values (especially notions of fairness and 
equity between socioeconomic groups, regions and generations) play major roles in all 
countries in shaping health and social care financing systems and in determining what sorts 
of reforms are considered acceptable by citizens. This can lead to change being incremental 
or even to no change at all. In Sweden it was suggested that: 
’Rights to health care will stay the same’ because it is ‘so deeply rooted in what [people are] 
expecting as a citizen’; providing adequate resources for health is considered to be ‘a matter 
of principle’ (Sweden Policy SE_3). Similarly, ‘all the political parties say that health care and 
elderly care and social care should be paid through taxes; there is no debate about it’ 
(Sweden Policy SE_1). 
Reforms have also generally been designed in a way that broadly maintains existing 
systems. The 2006 health care reforms in the Netherlands provide a good example. Pre-
2006, those on higher incomes, about 40% of the population at that time, had to purchase 
private health insurance, while the remainder of the population was covered through 
sickness funds.13 The system was then reformed to improve efficiency and achieve universal 
access, but a market competition model was chosen over a tax-based NHS-style model 
because the structures for insurance markets were already in place. 
In Finland it was observed that ‘under the previous government there was some 
consideration for an insurance-based system’, but ultimately the government ‘opted for a 
Nordic solution, a Scandinavian solution where there is tax-funded universal service system 
which is, by the way. more like the case of the NHS in England’ (Finland Policy FI_2). It was 
highlighted that the Finnish population did value the universal public service of the health 
system and dismantling it would be very challenging politically. 
The framing of the overall debate has been noted in some countries to be an important 
driver as well, presenting the health sector as an important part of the economy, as in 
Germany: 
‘Here, at least here we have the principle… we try to present publicly, as we did when we 
introduced legislation, when we introduced more services [and so] try to achieve willingness 
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from the public to pay more for it. So that health expenditure is not necessarily perceived the 
same way before as a burden, but actually as a very important economic branch of our 
country. We keep emphasising that the health sector especially can be viewed positively as 
far as employment is concerned but also where the economic factors are concerned, 
economic growth, innovation cycles etc.’ (Germany Policy DE_5).  
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6. Summary of key points of relevance 
to the UK 
 
 
In this paper we have outlined the variety of health and social care funding systems in high-
income countries. We have reported how selected countries configure their systems at 
present, whether and how this has changed or been interrogated in recent years, as well as 
important aspects of the funding environment which drive or constrain reform. Below, we 
summarise key points that have emerged from the review of selected countries and which 
we consider important to the identification of potential options for funding health and social 
care in the UK. We will test the relative public acceptability of different funding options, via 
focus groups and a discrete choice experiment, in the remaining stages of our research. 
6.1 Drivers and constraints 
The review of international experience highlighted what drives policymakers to consider 
changes to how they fund health and social care, and what constrains them when doing so. 
We found that health and social care financing reforms tend to be catalysed by changes in 
economic conditions rather than by rising demand for care. Concerns that instigate reform 
often arise from economic crises, or perceived crises. The ability to generate revenues, 
whether public or private, is inevitably dependent on the broader economy. In times of 
economic difficulty a common policy response has been to try to limit public expenditure, 
leading to concerns about how to pay for health and social care. This story is familiar in the 
UK and many other countries. 
It may appear a truism to say that political commitment and preference, alongside a 
perceived understanding of what is publicly acceptable, shape what funding reforms are 
considered in a given country. As the demand for health and social care grows steadily and 
progressively rather than in sudden, highly visible jumps, there can be political inertia, which 
prevents change to existing funding arrangements beyond relatively minor adjustments. That 
is a circumstance that affects all countries. However, a widely supported principle in one 
country, such as social solidarity as a basis for health care funding, may generate 
unwillingness to diverge significantly from a longstanding commitment to tax-based or 
mandatory insurance-based funding. But in another country, the weight accorded to social 
solidarity may be perceived as significantly weaker, with consequently greater willingness by 
policymakers to at least consider other funding options. Such differences of emphasis may 
apply across different parts of the UK, and we are investigating this in the latter stages of our 
research. 
This final section summarises the key points that have emerged from the review of 
selected countries and which we consider important to the identification of potential 
options for funding health and social care in the UK. 
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We have found that incremental change to health and social care funding arrangements is 
much more common than fundamental reform. But even in the case of more profound 
changes – such as the introduction of mandatory long-term care insurance in Germany and 
Japan – path dependency, societal values and country context are clearly key to shaping the 
options that are considered or implemented. For example, approaches to addressing 
perceived cost pressures in social care systems with high degrees of universal coverage for 
the whole population appear to emphasise reducing benefits and increasing co-payments, 
rather than fundamental reform that might threaten the principle of universality. The 
experience to date in all parts of the UK, with much social care paid for by private individuals 
rather than by the state, can be expected to have its own constraining effect on 
consideration of future funding options. 
Finally, the framing of the overall debate can be important, both as a driver of reform and a 
brake on it. We found Germany to be an interesting example of the scope for such framing, 
as there the debate about health care has included seeing it as an important sector in the 
economy, providing employment and opportunities for investment. 
6.2 Patterns in care funding internationally 
A few general patterns emerge when we study the landscape of health and social care 
funding systems of high-income countries. Health care funding is commonly heavily 
dependent on tax, as it is in the UK, or mandatory insurance; whereas social care often 
(though not everywhere) relies to a greater extent on private funding, as it does in all four UK 
countries. This difference between the two care sectors has the potential to lead to 
seemingly arbitrary boundaries between health care and social care within a country, 
according to how they are respectively funded. While the integration of health care funding 
with social care funding is an acknowledged priority in some countries, and is planned in 
Finland, there is little evidence of when and how and such integration will be taken forward 
elsewhere. 
The overall balance between public and private financing of health care or social care 
typically changes incrementally, if at all (other than as a result of definitional changes in data 
recording). In England the recently introduced Social Care Precept, allowing local 
government to increase council tax (a form of tax based on house values) by up to 3% per 
year to pay for more social care, is just such an example of important but incremental 
change. Despite the emphasis internationally on incremental changes, there remains 
considerable interest in reforming financing systems to make them more sustainable and 
predictable, and to raise additional revenues. No funding system that we reviewed has been 
entirely unaffected by change. 
Many countries raise taxes for health and/or social care at sub-national as well as national 
levels. Similarly, throughout the UK, local government contributes a minority of funding to the 
tax base for social care (via council tax and business rates), though it does not raise funds 
for health care. Our international review revealed no clear interest in either increasing the 
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reliance on locally raised taxes or, conversely, on greater centralisation at the level of 
national government. There are examples of movement in each of those directions. 
Reliance on public funding of health care remains strong across all countries included in the 
review; in some cases, publicly funded expenditure has increased at a faster rate than has 
total health expenditure. At the same time, in some countries there has been a focus on 
constraining public expenditure on social care, which implies greater reliance on expenditure 
by care recipients themselves. 
6.3 Specific changes to funding arrangements 
High-income countries have taken diverse approaches to tackling the need to increase 
health and social care funding. Internationally, no single optimal or commonly preferred 
solution to achieving sustainable revenues has emerged. Thus the international evidence 
does not signpost a single best path to follow for funding health and social care for the 
countries of the UK to follow. 
Debate and reform around the basis of entitlement to publicly funded social care has been 
growing internationally in recent decades, more so than in respect of health care. Perhaps 
most notable has been the adoption of mandatory insurance arrangements for funding 
(some) social care in a number of countries that originally operated – as the countries of the 
UK still do – safety net or means-tested systems: France, Germany, Japan and Korea. 
Accordingly, there has been, in effect, increased use internationally of mandatory 
contribution arrangements for funding social care. A citizen of those countries who pays the 
mandatory long-term care insurance premium knows that that money will be spent on long-
term care rather than merely adding to the total pot of government revenues that might be 
spent on any other area of public activity, as would be the case with general taxation. 
Although there are pressures on mandatory insurance contribution rates (not to let them rise 
continually), these systems continue to be sustained fiscally and appear to remain popular 
and politically acceptable (especially in Japan). 
Additionally, many countries have made changes to how access to publicly funded social 
care is needs-tested: changes affecting the treatment of informal care; and taking into 
account lifetime needs rather than just current needs. As regards the scope of the public 
benefits package for social care, accommodation costs are now covered by fewer systems. 
An innovation in the benefits package, elsewhere as in the UK, is the inclusion (and 
recognition as such) of publicly supported private financing solutions as non-care benefits. 
Beyond those countries with mandatory insurance systems, we did not find active 
consideration of earmarking/hypothecation of non-payroll-related taxes to fund health care or 
social care, other than to a very minor degree. This may be for a variety of reasons, 
including the unappealing pro-cyclical nature of relying on a single revenue source and the 
rigidity that hypothecated revenues introduce into budget setting, which is often unpopular 
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with ministries of finance. Hypothecation of any taxes to fund health and/or social care is not 
currently practised in the UK. There are near-precedents, such as the national television 
licence fee that is hypothecated to financing the BBC, although it, too, receives other 
sources of funding. National Insurance Contributions may be thought of by some as being 
hypothecated to fund the NHS, state pensions and welfare payments, but they are not 
hypothecated in practice and represent, rather, a tax on income from employment. 
More specifically, hypothecated revenue generation to fund health (or social) care through 
‘sin taxes’ – eg taxes on alcohol, cigarettes or sugary drinks – is not widely implemented or 
discussed in the countries included in the review, despite anecdotal popularity. Such taxes 
are seen as a way of incentivising healthier behaviours rather than as a significant source of 
funds for health (or social) care.  
Cost-sharing by care recipients – user charges, in other words – is more significant in social 
care than health care, with means-tested charges being a common and continuing feature. A 
number of countries are considering (further) increases in these charges, recognising the 
potentially dampening effects on demand as well as the revenue implications. For health 
care, countries have in some cases reduced or abandoned specific cost-sharing 
arrangements, in part due to negative public reaction to charges and to the limited revenue 
they generate. User charges in health care are contentious in the UK, too, and the devolved 
governments in Northern Ireland, Scotland and Wales have all taken the opportunity to 
abolish prescription charges. Nevertheless, no discussion of funding options would be 
complete without some thought being given to the role of user charges, even if they are 
ultimately rejected. 
Finally, we found that reliance on voluntary insurance as a source of either health care or 
long-term (social) care funding is not increasing. It is present in many countries in a 
complementary (insuring against patient charges and co-payments) or supplementary 
(financing improved or greater access beyond publicly funded health services) role. It has a 
supplementary role in funding health care in the UK, more so in England than in the rest of 
the UK, but none in social care. Voluntary insurance for social care has not made a 
significant addition to social care funding in any country we studied with the possible 
exception of France. 
6.4 Next steps 
The final stage of this two-year research project is to discuss the advantages and 
disadvantages of different ways of funding health and social care with a cross-section of the 
public, in focus groups and in a discrete choice experiment, in all four countries of the UK. 
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Appendix A: Expert Reference Group 
The members of the Expert Reference Group are: 
Professor David Bell – University of Stirling 
Anita Charlesworth – The Health Foundation 
James Lloyd – Formerly Director of the Strategic Society Centre, London 
Professor Marcus Longley – Welsh Institute for Health and Social Care, University of 
South Wales 
Professor Nicholas Mays – London School of Hygiene and Tropical Medicine 
Professor Ciaran O’Neill – Queen’s University Belfast 
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Appendix B: Analytical framework 
The configuration of health and social care systems of financing can be organised along the 
following dimensions:  
Coverage and 
benefits Basis for entitlement to publicly funded system 
  Benefits covered by publicly funded system 
  Degree of coverage 
  Generosity of benefits from public system 
Cost-sharing for 
publicly financed 
services For each type of provider/service: 
       Type of user charge 
       Level of user charge 
       Exemptions 
       Cap on user charge 
Collection Public funding sources (and % of total expenditure) 
  Private funding sources (and % of total expenditure) 
  % of population with private insurance coverage (and type) 
  Progressivity of financing 
Pooling Who is responsible for risk-pooling? 
Provision For each type of provider/service: 
       Public/private 
       Payment mechanisms 
Governance For each type of provider/service: 
       Who is responsible for decision-making? 
       Are decisions integrated with health/social care? 
Other Have there been attempts at financing reform recently? 
  
To what extent does macroeconomic policy drive the approach 
to health/social care financing? 
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Appendix C: Key informant interview 
topic guide 
Identifying options for funding health and social care in the UK: learning from 
international experience 
In light of the projected gap between funding and demand for health and social care services 
in the UK and elsewhere, there is a need for evidence to improve understanding about the 
pros and cons of the many options that are available. Informed by the international literature 
and the perspectives of representatives of policy, academia and the public, this study seeks 
to explore the acceptability of different options for the future funding of health and social care 
in the UK. By reviewing the international evidence around reforms to funding arrangements, 
and by engaging expert opinion via interviews, we aim to analyse current thinking about 
funding options and their implications. We hope that the interviews will also inform our 
understanding of the potential transferability of funding models and approaches to the UK.  
For interviewers: 
Remember to: 
• ask for permission to audio-record 
• ask for permission to acknowledge their contribution by name in final publication 
• clarify terminology: we are interested in the health/social care funding model in their 
country; ie how funds are raised from citizens/taxpayers/service users/patients. By 
‘social care’ we are referring to the equivalent of what is termed ‘long-term care’ in most 
SHI systems. 
Under any question where relevant, consider prompting on: 
• sub-national taxes 
• sypothecation 
o sin taxes  
o employer/corporate payments and taxes  
• compulsory insurance  
• charges/deductibles/hotel charges  
• tax and pension incentives  
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• welfare payments 
Key questions  
Introduction to the interview participant  
Could you briefly introduce yourself and your role and describe your area of expertise? 
Reforming health and long-term care funding: past experiences and ongoing/future 
proposals 
• Please describe any key recent past or ongoing reforms of your country’s 
health/long-term care funding system. NB: If the interviewer has a specific reform/set 
of reforms in mind, they should explore that instead of the generic question.  
o (Prompt on what is funded, how it’s raised, who’s entitled to it). 
o Consider prompting on: sub-national taxes; hypothecation (sin taxes, 
employer/corporate payments and taxes); compulsory insurance; 
charges/deductibles/hotel charges; tax and pension incentives; welfare 
payments.  
o Why were these reforms implemented? (What were the expected outcomes?) 
o Have there been particular barriers or facilitators that have had an impact on 
implementing financing reform? 
o Would you have implemented the reforms differently? 
o How well are the reforms working/meeting expectations? 
o What were some of the most important objectives when implementing these 
changes? (Prompts: efficiency, effectiveness, minimising bureaucracy, equity, 
public acceptability, sustainability) 
• To what degree has health/long-term care funding reform influenced the 
accessibility and quality of services? 
• What is the current thinking/debate about health and/or long-term care funding in 
your country? Are there any plans to further change health/long-term care 
funding arrangements and if so, how? 
o Consider prompting on: sub-national taxes; hypothecation (sin taxes, 
employer/corporate payments and taxes); compulsory insurance; 
charges/deductibles/hotel charges; tax and pension incentives; welfare 
payments.  
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o What are these proposed changes intended to address? 
o To what degree, if at all, are schemes being considered that are designed 
to target service users more directly through, for example, providing tax 
credits for private insurance; cash benefits for providing informal care, 
etc? 
• How likely is it that any of the above changes will be implemented? Why/why not? 
• Are there particular options for health or long-term care funding that have been 
ruled out? Why? (eg more charging, co-payments, hypothecation – see above 
list) 
• Have there been any funding reforms/consideration of ways to affect the 
behaviour of patients and/or service users? (E.g enabling individual decision 
making, hypothecation, insurance, tax/pension incentives, encouraging supply of 
informal care).  
o [France SC: in comparison with other OECD countries, France has a 
significantly large, voluntary, private long-term care insurance system. 
Recent proposals to expand the take-up of private insurance were 
unsuccessful. Why was this?] 
• Have there been any funding reforms/consideration of ways to better enable 
people to pay for their own care? (Eg welfare payments, equity release 
schemes).  
o [Austria SC: a substantial amount of long-term care resources is provided 
in the form of cash benefits, which is in turn used to pay for informal care 
among other options. Are there plans to further promote use of informal 
care? (eg assistance and training available to carers)] 
• Has the integration of health and long-term care funding been considered in your 
country?  
o What barriers or incentives are there for this?  
o Has this been reflected in any debates and reforms around the integration 
of health and long-term care provision?  
o [Finland SC: now looking at integrated provision of health and long-term 
care, what were the barriers and incentives found so far? How do you 
ensure adequate funding and provision of services are standardised 
across all municipalities?]  
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The role of taxes in health/long-term care funding (if these questions have already been 
answered in response to earlier questions, do not repeat them) 
• [For SHI countries] What is the role of taxation for funding health/long-term care 
in your system?  
o What are the plans (if any) to change the degree to which health/long-
term care is funded through taxation and why?  
• [Sweden SC: social care in your country has been known to be quite 
decentralised for both funding and provision. How does the government deal with 
variation in local tax revenue that can potentially affect the availability of care 
across municipalities?] 
• What is the nature of taxes that are being raised at the various levels in the 
system (national, regional, local) to fund/subsidise health/long-term care? 
o [Prompts: income taxes, corporate taxes, sin taxes, etc.] 
o Has this changed in recent years and if so, how?   
o Are there plans to change this in future and if so, why and how? 
• Who decides at what level (national/regional/local) taxes for health/long-term care 
should be levied?  
• What powers do the different levels have to decide how much to raise and how to 
allocate these? 
o Has this changed in recent years and if so, how?   
o Are there plans to change this in future and if so, why and how? 
What is the current thinking (if any) to experiment with innovative forms of taxation in order 
to (help) fund health/long-term care?  
The role of payments by service users in health/long-term care funding (if these 
questions have already been answered in response to earlier questions, do not repeat them) 
• What is the role of co-financing – i.e. co-payments, deductibles and user charges 
by patients/service users – for funding health/long-term care in your system?  
o What are the plans (if any) to change the degree to which health/long-
term care is funded through co-financing and why?  
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• What is the current thinking (if any) to experiment with innovative forms of co-
financing in order to (help) fund health/long-term care?  
Factors affecting decision-making on health/long-term care funding reforms 
• How predictable is income or revenue for health/long-term care funding and how 
does this affect decision-making? 
o [Prompt on macroeconomic constraints, demographic changes, other?] 
• How have decisions on health/long-term care funding been influenced by the 
considerations about the wider economy? (Prompts: funding gaps, 2008 crisis 
and recovery (where relevant)) 
• What arrangements are in place to overcome or ‘buffer’ against fiscal pressures 
on health/long-term care funding? 
o When have these been introduced and what effect have they had? 
o If no such arrangements are in place, are there any plans to do so and 
what would these entail? 
• Considering the various factors that will impact on decision making on 
health/long-term care funding, which ones do you believe have been most 
important and why? 
o public opinion [prompt: trust versus expectations versus acceptability] 
o political constraints/beliefs 
o interest groups  
o system goals and values [prompts: fairness, intergenerational solidarity, 
etc.] 
o other  
o [Japan SC: premium contributions to long-term care insurance are made 
only by employees and pensioners 40 years or older. How was this 
decision made and are there any plans to change this? Why (or why 
not)?]  
o [Germany SC: childless workers contribute more towards long-term care 
insurance. What are the reasons for that?] 
Wrap up and close 
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• Can you suggest any documents or data sources which would help us answer 
the above questions?  
• Would you recommend any other experts who we should talk to about health and 
social care funding in your country? 
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Appendix D: Entitlement and coverage for 
publicly funded health and social care 
Publicly funded health care: entitlement and coverage 
Basis for entitlement to publicly funded health care benefits 
The majority of countries included in the review provide (almost) universal coverage, with 
citizenship and/or legal residence in the given country being the most common basis for 
entitlement to health care. For example, in Australia, entitlement includes Australian citizens, 
residents with a permanent visa, and New Zealand citizens, following their enrolment in 
Medicare and confirmation of identity. In statutory insurance systems, entitlement is typically 
tied to employment status, with dependents included free of charge as noted above. For 
example, in France SHI coverage is almost universal (99.9% of the population in 2013). 
Those with an annual household income of under €9,534 (2013/14) are covered (free of 
charge) by CMU (universal health insurance); transitory foreigners and undocumented 
migrants who have lived in France for at least three months are eligible for free coverage 
under state medical assistance (AME) for those whose income is below the CMU threshold. 
At the end of 2014, there were 294,300 beneficiaries of AME and related expenditure 
equated to about €720m (0.5% of total expenditure of SHI of €146.2b). Other beneficiaries 
must pay an annual premium equal to 8% of revenues above the ceiling.11 
Likewise in Germany, anyone legally residing or working in Germany who holds a legal 
employment contract enters the SHI system and contributes monthly payments. SHI costs 
for the unemployed and for those on benefits are paid for by the state. In Japan, all residents 
are required to enrol in one of two schemes: the health insurance system for employees and 
their families (60% of the population) or the national health insurance (NHI) system for the 
self-employed, retired and unemployed (40%), which is administered by local government. In 
Korea, the majority of the population is covered by compulsory national health insurance 
while the very poor are covered by the medical aid programme. 
The US has so far been an outlier in that it did not offer universal access to health care; 
instead entitlement to publicly funded services was dependent on certain conditions, with 
Medicare providing healthcare for those aged 65 years and over, Medicaid for those under a 
certain income threshold or the Veterans Health Administration for veterans of the armed 
forces. However, with the 2010 Patient Protection and Affordable Care Act (ACA), health 
care coverage is gradually being expanded, requiring all residents to obtain health insurance 
or pay a financial penalty if they do not. Under the ACA, from 2014, Medicaid coverage has 
been extended to low-income adults in states that have opted to expand eligibility, and tax 
credits have been made available for middle-income people who purchase private coverage.  
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Benefits covered by the publicly funded health care system 
The scope of services covered under the statutory system is fairly similar among countries 
included in the review, with all systems offering a basic basket of services, including general 
practitioner and specialist care, and hospital inpatient and outpatient services. There is, 
however, variation in relation to services such as mental health care, rehabilitation, dental 
care and optometry. For example, in France, patients are entitled to access a 
comprehensive set of health care services, including hospital care and treatment in public or 
private facilities providing health care, rehabilitation or physiotherapy; outpatient care; 
diagnostic services and care; pharmaceutical products, medical appliances and prostheses 
prescribed and included in the positive lists of products eligible for reimbursement; and 
prescribed health care-related transport.11 In Germany, health care covered under SHI 
includes preventive services, ambulatory and hospital care, mental health care, dental care, 
optometry, physical therapy, prescription drugs, medical aids, rehabilitation, hospice and 
palliative care, and sick leave compensation.12 A similar range of services is also offered in 
Japan, with all insurance plans providing the same national benefits package, covering 
hospital care, ambulatory care, mental health care, approved prescription drugs, home care, 
physiotherapy, and most dental care. Some preventive measures are publicly provided to 
those aged 40 and older, including screening, health education and counselling.14 
In Canada there is no nationally defined statutory benefits package although provinces and 
territories must provide coverage of medically necessary physician, diagnostic, and hospital 
services (including inpatient prescription drugs) for all eligible residents in order to qualify for 
federal financial contributions.84 Most public coverage decisions are made by provincial and 
territorial governments in conjunction with the medical profession. Provinces and territories 
provide varying levels of additional benefits, such as outpatient prescription drugs, non-
physician mental health care, vision care, dental care, home health care, and hospice care. 
A number of countries explicitly exclude selected services from coverage under the public 
systems. For example, in Italy the public benefits basket does not include dental care and it 
also operates negative lists defining what is not covered at all, such as cosmetic surgery, 
services that are covered only on a case-by-case basis (for example, orthodontics and laser 
eye surgery) and services for which hospital admissions are likely to be inappropriate (for 
example, cataract surgery).85 Regions can choose to offer services that are not included in a 
nationally defined benefits package (essential levels of care) but must finance them 
themselves.86 Korea also excludes patient transportation, glasses and contact lenses along 
with services that are not considered essential to daily living such as plastic surgery and 
high-cost services.15  
Most systems include prescription drugs within the publicly funded basket of services but 
they usually require patient co-payment (see below). 
Among the countries included in this review, access to specialist services tends to require 
referral. Most countries have assigned a gatekeeping role to general practitioners (GPs). 
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France, Germany, Switzerland and the USA have put voluntary gatekeeping arrangements 
in place, with the ‘preferred doctor’ scheme in France including financial incentives 
encouraging residents to sign up with the scheme. In Australia, specialists can claim a 
higher rebate when the patient is referred by a GP, while in France and Sweden, patients 
may access specialist care directly, although they must make a co-payment to do so. In the 
Netherlands, the basic basket of services covered under the statutory system includes GP 
care, maternity care, hospital care, home nursing care, pharmaceutical care and mental 
healthcare. The first €385 (in 2016) of expenditure from this package is paid out of pocket, 
except for GP consultations, maternity care, home nursing care and care for children under 
the age of 18. 
Publicly funded social care: entitlement and coverage 
Countries vary widely in terms of who is covered by publicly funded social care and for what 
types of service; and there is active consideration given in many countries to changing 
entitlements to publicly financed social care and the benefits it covers. With some notable 
exceptions, many countries which historically have, as the UK still does, operated with safety 
net or means-tested public funding of social care (with a heavy reliance on private family or 
charitable solutions) have seen important changes. A trend has been the introduction of 
social insurance systems to fund LTC; this is discussed in more detail in section 4. Germany, 
Japan, France and Korea are examples of countries that have implemented mandatory long-
term care insurance (LTCI) systems in the last 20 years or so. One of the key rationales – as 
expressed particularly in the German case – was concern about the potential for indignity 
and stigma associated with people having to seek means-tested social assistance to meet 
care needs.87 The introduction in 2002 of the French LTC insurance system (the Allocation 
Personnalisée d’Autonomie, APA) was precipitated by the view that the risk of developing 
LTC needs should be addressed collectively.88 
Other countries have also made attempts to implement a mandatory LTCI scheme or had 
this as a core recommendation from various public commissions or other inquiries into the 
funding of LTC. Both in the USA and Australia, public commissions have put forward options 
for mandatory LTCI: the 2011 Productivity Commission on Disability Care and Support in 
Australia, and the 2013 Federal Commission on Long-term Care in the USA. However, 
concerns about the political acceptability of potentially expensive LTCI programmes remain 
effective barriers to the implementation of these reforms. 
A number of countries continue to operate with safety net means-tested arrangements for 
social care, including the USA, Australia and Ireland, as well as the four countries of the UK. 
Eligibility for publicly funded social care is conditional on income and in some cases, income 
and assets. People with insufficient financial means to afford care are supported, although 
the threshold for eligibility varies between countries and sometimes between sub-national 
localities. There is widespread recognition of the limitations of safety net systems and all of 
these countries have had public commissions and inquiries of various sorts, which have 
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proposed alternative, more universal recommendations. Central to the debate are tensions 
between the benefits and costs. On the one hand, the benefits of LTCI through publicly 
funded risk-pooling (recognising that private market solutions tend to fail in this area) and 
improved fairness/dignity from reduced means-testing are identified. On the other hand, 
there is the perceived issue of the impact on public finances of these alternatives. 
Nonetheless, pressure to reform towards systems with more universal entitlement clearly 
remains significant (and this pressure will potentially grow, given the ageing of the population 
and concerns about expansion of morbidity). 
While we can identify the pressure to move away from means-testing, in countries with high 
degrees of universal coverage we can also see concerns about the continued affordability of 
these systems. Approaches to addressing the perceived cost pressures appear to be 
through reducing benefits and increasing co-payments or by increasing contribution rates in 
hypothecated systems, rather than by more fundamental reform. In Germany and Japan, for 
example, LTCI contribution rates have been increased over time.  
As regards the basis for entitlement to publicly funded social care support, all systems, 
including in the UK, involve needs-testing with assessment of physical and cognitive 
functioning to some degree. Need-severity thresholds of various sorts limit entitlement or 
eligibility. An important consideration is whether the availability of informal care support is (or 
should continue to be) included in the needs test. For example, in England, public authorities 
can reduce benefits if some needs are being met with the help of an informal carer, although 
changes to the eligibility framework in 2014 have altered how far this can be done. The 
mandatory public LTCI systems are mainly ‘carer-blind’ in that the availability of informal 
care does not affect entitled benefits. 
Direct payments to care users from public funds are available in England and are meant to 
provide more care options for users according to the Care Act 2014, and therefore should be 
enough to purchase LTC services similar to the ones provided by local authorities. Scotland 
has a similar arrangement of cash benefits according to the Social Care (Self-directed 
Support) Act 2013. In Germany, beneficiaries can opt to take a cash payment – principally to 
support (informal) carers – valued at half of the cost of the in-kind services option. Also, 
those without children are required to pay a slightly higher LTCI contribution rate. As such, 
the German system does take some account of the availability of informal care. 
A recent innovation as regards entitlement and eligibility is for public funding support to be 
provided on the basis of accumulated or lifetime care needs, not just current need. The 
Dilnot Commission’s capped risk model (proposed but not implemented) for England is an 
example.89 In short, eligibility is determined not only on the basis of the current level of need 
but also on the cumulative assessed cost of meeting an individual’s needs over the person’s 
lifetime. This is very similar to the Australian lifetime cap on LTC costs borne by any 
individual. Once that expenditure limit is reached, care is publicly provided free of charge to 
the care recipient. In Germany, a slightly different system applies where annual thresholds 
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are in place, set at 2% of annual gross household income, but only for care covered by the 
mandatory LTCI.12 
With regard to types of care services covered by publicly funded social care/LTC, most 
systems include home-based personal care. However, most systems, including the UK 
(apart from Scotland), do not fully cover ‘practical’ or domestic care costs, even if that need 
is linked to disability, which means that care users have to meet these extra costs. 
Furthermore, accommodation costs for residential forms of care are often not covered by 
public funding, although in all countries of the UK some support in paying such costs is 
currently available: care users and local authorities can negotiate how they share the costs 
of care if the user is not able to afford it. 
The generosity of publicly funded social care benefits differs between countries. In Germany, 
benefits from the LTCI system are relatively modest, covering as little as a half of the total 
assessed costs of care. Similarly, in France the APA system is not expected to cover the full 
costs of care (covering on average around two-thirds of the cost). In Japan, on the other 
hand, benefits are more generous. In the means-tested systems, the principle is generally to 
provide the full amount of assessed care and support levels, although subject to charges.  
A recent pattern across a number of countries – particularly in those with entitlement-based 
systems – is a tightening of the needs test: reducing access for people with lower levels of 
need and placing more reliance on private funding. For example, reforms in Japan in 2005 
redefined, and in doing so reduced, levels of publicly funded support for lower needs groups. 
Before 2005, people with lower levels of need received care services, whereas now they 
receive (lower cost) preventive services instead, such as home visits by nurses, the purpose 
of which is to avoid or delay demand for more expensive care services.90 Furthermore, with 
these reforms the costs of accommodation in care homes, which were covered in the original 
scheme, have become subject to a means test, reducing effective coverage by the LTCI 
system to around half the costs of accommodation.  
A further option for social care is the provision of publicly supported private financing 
solutions as non-care benefits, in addition to conventional care and service benefits. Publicly 
backed financing solutions can help people to pay for the care they need, a benefit that is 
especially relevant in systems with significant out-of-pocket payment requirements. 
Examples include publicly operated and underwritten equity release schemes. Care users 
can benefit from the relative security of a publicly operated system and preferential interest 
rates. England’s deferred payment arrangements (DPAs) system is an example.* There are 
                                                
* DPAs for social care are offered to people who have local authority-arranged care in England, and to people 
who arrange their own care, provided their eligible needs are to be met by care provided in a care home. A 
person can delay paying the costs of their care until death; or can choose to use the deferred payment as a 
‘bridging loan’ to give them more flexibility in deciding when to sell their home. The 2014 Care Act made it 
obligatory for local authorities to offer DPAs, although they had already been made available by some local 
authorities before 2014. 
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also proposed innovations that seek to more closely align the benefit/pension system with 
the self-funding of LTC. An example is a disability-linked annuity in the pension system.*  
 
 
                                                
* A disability-linked annuity means that regular annual pension payments received by an individual are reduced a 
little, eg 10%, but in return the pension payments will be greatly increased, eg doubled or trebled, at the point that 
the individual develops a need for social care (eg is no longer able to perform certain activities of daily living) or 
reaches a particular age (eg 85). 
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Appendix E: Cost-sharing arrangements for selected service areas 
internationally 
Table E1: Cost-sharing arrangements for selected service areas in 13 countries 
 Primary care/GP services Specialists outside 
hospital /specialist 
outpatients 
Inpatient care Dental care Comment 
Australia GP visits are subsidised at 100% of 
the Medicare Benefits Scheme (MBS) 
fee 
GPs can choose whether to charge 
above the MBS fee (in 2014/15, ~83% 
of GP visits were provided without 
charge to the patient)  
Patients who were charged paid an 
average of AUD 31 
Visits are subsidised at 
85% of the MBS fee 
Specialists can choose 
whether to charge above 
the MBS fee. 
Free for public Medicare 
patients in a public 
hospital 
Full payment required for 
most services except 
some selected 
procedures 
New safety net arrangements for GP 
and outpatient specialist costs are 
subject to passage of legislation 
(2016). Medicare will reimburse 80% of 
out-of-pocket costs (up to a cap of 
150% of MBS fee) for the remainder of 
the calendar year once annual 
thresholds are met:  
- AUD 400 for concessional patients 
(including low-income adults, children 
under 16, certain veterans); 
- AUD 700 for parents of school 
children and singles;  
- AUD 1,000 for all other families 
Canada None None None Full payment required for 
most services; about half 
of privately funded 
dental care is funded 
Those receiving social assistance and 
First Nations or Inuit are exempt from 
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 Primary care/GP services Specialists outside 
hospital /specialist 
outpatients 
Inpatient care Dental care Comment 
through VHI, the majority 
of which is through 
employment-based 
plans 
or are entitled to reduced co-payments 
for dental care 
Finland €13.80 per visit; a single primary care 
centre cannot collect this co-payment 
more than three times per year 
Annual cap on costs 
€27.50 per visit 
Outpatient surgical 
procedures: maximum of 
€90.30 per procedure 
Annual cap on costs  
€32.60 per day in 
somatic care; €15.10 
per day in psychiatric 
care 
Annual cap on costs 
€7.50 with a dental 
hygienist, €9.60 with a 
dentist, €14 with a 
specialised dentist, plus 
procedure-specific co-
payments 
Children are exempted from co-
payments for dental care and 
prostheses 
France 30% of cost plus €1 co-payment 
Annual cap on user charges of €50 
Exemptions: preventive services incl. 
mammography, cervical screening, 
compulsory/recommended 
immunisations; ante/postnatal care) 
Outpatient treatments: €18 
for treatments with a tariff 
over €120 (can be charged 
only once per visit) 
20% + €18/day for 
accommodation 
SHI covers all costs 
from day 31 of hospital 
stay 
Exemptions: maternity 
care from the last four 
months of pregnancy 
until 12 days 
postpartum; newborns in 
the first 30 days 
Data not available Beneficiaries of CMU-C and AME are 
entitled to free vison care and free 
dental care  
Exemption from co-insurance apply to: 
- those with any of 32 specified chronic 
illnesses (ALD) for treatment of these 
conditions 
- CMU-C and AME beneficiaries 
- beneficiaries of invalidity and work-
related injuries insurance 
- disabled children under age 20 living 
in institutions 
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 Primary care/GP services Specialists outside 
hospital /specialist 
outpatients 
Inpatient care Dental care Comment 
Children and people on low incomes 
(CMU, AME) are exempt from paying 
non-reimbursable co-payments 
Germany A charge of €10 per quarter for first-
contact care [GP, specialist in 
ambulatory care; dentist] and for visits 
of other physicians without referral 
during the same quarter was abolished 
in 2012 
See GPs €10 per calendar day for 
maximum of 28 days per 
calendar year  
 
 
Co-insurance for crowns 
and dentures at 35-50% 
of cost; co-payment 
reduced for those who 
can demonstrate regular 
dental check-up 
Children under age of 18 years are 
exempted from co-payments for 
inpatient and dental care 
Italy None Varies according to region 
but with a ceiling per visit 
(2014: €36.15 plus €10 per 
prescription i.e. per 
separate service provided) 
 
None  Full payment of costs 
required 
 
Children under age six; people aged 
65+; people with severe disability; 
those on low incomes; the unemployed; 
prisoners; people with chronic or rare 
diseases are exempt from co-payments 
for outpatient services, as are those 
with HIV and pregnant women, who are 
exempt only for services related to their 
condition 
Children under age 14, people with 
severe disabilities, those on low 
incomes and other vulnerable groups 
are exempt from payment for dental 
care 
Japan 30% of costs See GPs 30% of costs 30% of costs People over 65 with disabilities and all 
people over 75 are entitled to reduced 
co-payments for medical services for 
physical disabilities and mental 
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 Primary care/GP services Specialists outside 
hospital /specialist 
outpatients 
Inpatient care Dental care Comment 
Monthly co-payment cap depending on 
age and income 
 
Monthly co-payment cap 
depending on age and 
income 
Monthly co-payment cap 
depending on age and 
income 
disorders. For these individuals, the co-
payment for primary, outpatient and 
inpatient care per month is means-
tested on household income, and is 
limited to 10% of the costs for a 
medical service 
Exemptions from or reduction of all co-
payments including for dental care for 
patients covered by the social 
assistance programme and under a 
certain income threshold. Reductions 
on cost-sharing for children 
Korea 30% of costs of service 
Expense limit for all cost-sharing is 
based on the average health insurance 
fee per year 
 
Tertiary hospitals: 60% 
cost-sharing (100% for 
medical examination fee); 
general hospitals: 50% 
cost-sharing (45% in rural 
area); other hospital: 40% 
cost-sharing (35% in rural 
area); doctors' clinic: 30% 
cost-sharing 
Expense limit for all cost-
sharing is based on the 
average health insurance 
fee per year 
 
Co-insurance of 5-10% 
for medical services 
provided for severe 
diseases, 20% for other 
medical services; and 
50% on meals 
Expense limit for all 
cost-sharing is based on 
the average health 
insurance fee per year 
 
30-60% cost-sharing 
depending on level of 
referral of the facility 
Expense limit for all cost-
sharing is based on the 
average health 
insurance fee per year 
 
Patients with certain severe diseases 
are exempt from cost-sharing or pay 
reduced co-insurance 
Reduced cost-sharing for patients over 
65 for primary care services: 30% when 
total cost exceeds KRW 15,000 and co-
payment of KRW 1,500 if the total cost 
is lower. Reduced cost-sharing also for 
outpatient specialist services for 
seniors 
Medical Care Cost Support 
programmes provide subsidies to the 
high-risk patients, including 132 
disease categories where their income 
is less than 300% of the minimum cost 
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 Primary care/GP services Specialists outside 
hospital /specialist 
outpatients 
Inpatient care Dental care Comment 
of living, or if they are enrolled in the 
Medical Aid programme 
Exemptions or reduction on all cost-
sharing for primary, specialist 
outpatient, inpatient and dental care for 
patients under a certain income 
threshold. Children are exempt from 
cost-sharing for all services 
Netherlands None Varies 
Annual cap 
Varies 
Annual cap 
Full payment required 
 
As of 2015, every insured person over 
age 18 must pay an annual deductible 
of €375 for health care costs, including 
costs of hospital admission but 
excluding some services, such as GP 
visits 
Patients with an in-kind insurance 
policy may be required to share costs 
of care from a provider that is not 
contracted by the insurance company 
Children under age 18 are exempt from 
co-payments for all services including 
dental care.  
Low-income households are entitled to 
subsidies (health care allowances) 
subject to asset testing and income 
ceilings, to cover community-rated 
premiums  
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 Primary care/GP services Specialists outside 
hospital /specialist 
outpatients 
Inpatient care Dental care Comment 
New 
Zealand 
Co-payments for GP consultation 
average between NZD 15 and NZD 45 
but they vary significantly, as there are 
no limits to these set by GPs 
Exception in low-income areas, where 
a higher annual per-patient capitation 
rate is paid and where patient co-
payments are capped at NZD 17.50 
per visit 
None  None  Data not available Children under age six are exempted 
from cost-sharing for primary care; co-
payments are reduced for children age 
six-18 
Sweden Per visit, level determined by county 
council, varies between SEK 100 and 
SEK 300 
Annual cap of SEK 1,100 for all GP 
and outpatient visits 
 
Per visit, level determined 
by county council, between 
SEK 200 and SEK 350 
Annual cap of SEK 1,100 
for all GP and outpatient 
visits 
 
Co-payment varies by 
county-council, between 
SEK 80 an SEK 100 
Reduced co-payment for 
low-income populations 
in some counties 
Deductible, then co-
payment 
Prevention: fixed general 
annual subsidy of SEK 
150-300; dental care: 
deductible of SEK 3,000 
and then 50% co-
insurance up to SEK 
15,000, then 15% co-
insurance  
There is no cap on user 
charges for dental care 
Children under the age of 18 are 
exempt from cost-sharing for most 
services including dental care in all 
counties (in most counties this extends 
to all those aged under 20) 
Patients with certain medical conditions 
and disabilities are exempt from cost-
sharing for primary care but this can 
vary among counties 
Co-payments for inpatient care are 
reduced for people on low incomes in 
some counties 
Switzerland Co-insurance: 10% of cost after 
deductible 
Annual cap of CHF 700 for adults and 
CHF 350 for children 
See GP services 10% co-insurance after 
deductible plus CHF 15 
co-payment per day 
Annual cap of CHF 700 
for adults and CHF 350 
Full payment Children have no or reduced deductible 
(depending on plan chosen). Pregnant 
women are exempt from all cost-
sharing 
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 Primary care/GP services Specialists outside 
hospital /specialist 
outpatients 
Inpatient care Dental care Comment 
for children; cap does 
not apply to the daily co-
payment of CHF 15 
Children have no or reduced deductible 
(depending on plan chosen). Pregnant 
women are exempt from all cost-
sharing. Young adults in training (under 
26 years) are exempt from co-
payments. 
USA Medicare Part B: deductible of USD 
147 deductible and then 20% of 
Medicare-approved fees (plus 15% 
extra billing if the provider does not 
accept Medicare rates) 
See GP services Medicare Part A: 
deductible of USD 1,216 
for each hospital 
admission; co-payment 
of USD 304 per day 
between days 60 and 90 
 
Full payment required 
 
Most Medicare and Medicaid 
programmes apply co-payments and 
deductibles, with exemptions for people 
who have paid for health expenditure 
above a certain threshold. Medicaid 
generally requires lower cost-sharing 
 
Table E2: Cost-sharing arrangements for selected service areas in social care in 11 countries 
Country Nursing homes Community-based services (home care) Comment 
Australia The maximum basic daily cap is 85% of the single 
person basic old age pension. This is adjusted every 
20th March and 20th September. Up until 20th March 
2017 this rate is AUSD 48.44 a day [GBP 29.7]. The 
maximum accommodation supplement is AUSD 54.39 
[GBP 33.4]. Lower income earners are exempt after 
means test. 
There is a smaller daily cap at AUSD 9.97 [GBP 
6.11], up to AUSD 28.61 [GBP 17.55], depending 
on income. 
Low-income earners have reduced daily fees and may 
be exempt from accommodation fees in case of 
admission to residential care. 
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Country Nursing homes Community-based services (home care) Comment 
Austria In general, individuals are responsible for paying for 
their residential care out of their income/pension and 
assets. However, they are allowed to keep some of 
their pension (20%) and cash allowance (10% at 
grade level 3). The remainder of the cost is covered by 
the social assistance provider. 
A similar arrangement is in place. The highest 
level of care need, level seven, entails a cash 
allowance of €1,688.90. 
Care homes receive up to 90% of the service user’s 
cash allowance plus up to 80% of their pension. 
Finland Fees are dependent on ability to pay and are agreed 
with the municipality, the client and the institutional 
care home that will provide the service. 
 
A 1992 law sets the charges according to the 
user's income and how many people share the 
household. A user living alone will pay 35% of 
any monthly income above €520 as fees (i.e. the 
percentage is applied on the surplus income) 
while someone living with another five people will 
pay 11% of any monthly income above €2,585. 
Fees should never be more than the cost of care and 
there are two caps indicated by another 1992 law. The 
fees cannot exceed 85% of the user's monthly income 
and there must be at least €90 left, per month, after 
fees are paid. 
France Depends on income. Users with income below 
€799.73 a month do not pay and the wealthiest in the 
income bracket (above €2,945.22 a month) pay 90% 
of care costs. 
Individuals are expected to make their own 
arrangements for home care if they choose to live 
at home. Payment is agreed with the service 
provider, usually a close relative or professional 
caregiver. Spouses/partners cannot receive 
compensation from APA, but other relatives can 
be paid with the benefit. 
Low-income care users do not have to make any 
financial contribution. In 2014 the threshold was a 
monthly income of €689.5. Elders with income below 
that amount did not have to pay user fees. 
Germany The LTCI funds repay the care user up to the limit 
according to the care level but accommodation costs 
are not covered. For grade 5, including cases of 
hardship, the maximum refundable cost is €2,005. 
Any cost beyond the limits according to the level 
of care has to be paid by the care user.  
Exemptions apply once a cap has been reached and 
the user is defined as in need of care grade II or III 
(the system was recently replaced in 2017 to a 5-point 
grade; current exemptions are unclear). For these 
individuals, if annual costs with co-payment have 
reached 1% of annual household income, then they 
are eligible for exemption from user charges. 
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Ireland Payments vary according to income but never exceed 
the actual cost of care. Up to 80% of income and 7.5% 
of the value of any assets per year can be charged. 
 
The home care package helps a person to be 
cared for in their own home. There is no charge 
for regular services (home care, nursing care, 
physiotherapy, etc) as they are part of the public 
health service. 
There are caps on costs: 20% of the service user’s 
income or 20% of the maximum rate of the state 
pension, whichever is greater, will be kept by the user. 
The first €36,000 of an applicant's assets are not 
considered. If the user has a spouse/partner at home, 
50% of the couple's income or the maximum rate of 
state pension is kept, whichever is greater. 
Japan The co-payments are means-tested. Low-income 
users can be exempt from payment while high-income 
earners pay 20% of costs. General service users must 
pay 10% of total cost of LTC at nursing homes but the 
patients must pay full cost of accommodation and 
meals. These additional costs can raise total cost-
sharing to 30% of total, on average. 
The same fees apply. Exemptions are available for low-income individuals. 
In 2014. caps were as follows: YEN 37,200 [USD 
354.3] a month for standard users, YEN 24,600 [USD 
234.29] for municipal tax-exempted households and 
YEN 15,000 [USD 142.86] for old age pensioners. A 
separate cap was used for meal costs which were, 
according to the categories, YEN 23,400 [USD 
222.86], YEN 15,000 [USD 142.86] and YEN 9,000 
[USD 85.71], respectively. 
Korea Charges for residential care are equal to 20% of cost 
of services. 
Charges for home care are equal to 15% of cost 
of services. 
There are exemptions for users with low-income under 
the National Basic Living Security Act. For them, co-
payments are cut in half (i.e. 7.5% for home care and 
10% for residential care). 
Netherlands Charges depend on duration of care and user's 
income. For the first six months of care, all users pay 
12.5% of their income towards LTC costs; the 
remaining costs, if any, are covered by public funds. 
The minimum monthly payment is €159 and the 
maximum is €833 (in 2015). After six months, users 
with partners or dependent children at home continue 
to pay the low co-insurance, but all others start paying 
all of their taxable income plus 8% of their assets. 
For home care, municipalities and care users 
agree on the charges. Municipalities cannot 
charge more than the maximum LTC Act 
contribution, which is 9.65% of income (2016), 
but they can set their own maximum out-of-
pocket payments. Low-income individuals may 
have their fees waived by the municipality. 
For residential care, the high co-insurance rate has a 
cap of €2,285 per year. There is also a minimum 
allowance that the user has the right to keep per year: 
€3,517 for singles and €5,471 for couples. 
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Sweden The cost of care depends on the type of care needed 
and the user's income. They are decided by 
municipalities and respect the maximum national 
monthly cap of SEK 1,760 (2016).  
The same rules and fees apply to home care. There is a monthly minimum allowance of SEK 5,000 
(USD 547.65), ie no fees should be charged if the care 
user earns less than this amount or will be left with 
less than this amount per month after paying fees. 
USA In April 2016, the monthly cost of a semi-private room 
in a nursing home was USD 6,844; a private room was 
USD 7,698. If using Medicare, 100% of expenses are 
paid by public funds for the first 20 days; for 21-100 
days the user pays for their own care up to USD 140 
per day. Medicare pays the remaining balance. 
The average monthly cost for home care services 
was USD 3,813, the use of a home health aide 
providing assistance for personal care was USD 
3,861 monthly and the average cost for spending 
the day at an adult day health care home was 
USD 1,473. 
Exemptions are unclear on a national level as each 
state has different approaches to coverage by public 
funds, but on average there is a sliding scale available 
for low-income individuals that pay charges out of 
pocket.  
 
 
